Omega Protein (OME) 10-Q 11 May 15 2015 Q1 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Mar. 31, 2015	4-May-15
Document and Entity Information [Abstract]
Entity Registrant Name	Omega Protein Corp
Document Type	10-Q
Current Fiscal Year End Date	-19
Entity Common Stock, Shares Outstanding		21,718,072
Amendment Flag	FALSE
Entity Central Index Key	1053650
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	31-Mar-15
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1

Unaudited_Condensed_Consolidat

Unaudited Condensed Consolidated Balance Sheet (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Current assets:
Cash and cash equivalents	$223	$1,430
Receivables, net	41,954	36,621
Inventories	93,551	97,513
Deferred tax asset, net	1,845	1,871
Prepaid expenses and other current assets	4,083	4,936
Total current assets	141,656	142,371
Other assets, net	2,176	2,309
Property, plant and equipment, net	175,579	169,932
Goodwill	41,945	42,501
Other intangible assets, net	22,197	23,002
Total assets	383,553	380,115
Current liabilities:
Current maturities of long-term debt	18,379	14,741
Accounts payable	19,173	21,047
Accrued liabilities	23,140	23,216
Total current liabilities	60,692	59,004
Long-term debt, net of current maturities	21,296	20,486
Deferred tax liability, net	24,949	25,949
Pension liabilities, net	4,968	5,375
Other long-term liabilities	4,229	3,419
Total liabilities	116,134	114,233
Commitments and contingencies
Preferred stock, $0.01 par value; 10,000,000 authorized shares; none issued	0	0
Common Stock, $0.01 par value; 80,000,000 authorized shares; 21,793,094 and 21,587,751 shares issued and 21,718,072 and 21,527,319 share outstanding at March 31, 2015 and December 31, 2014, respectively	212	210
Capital in excess of par value	143,393	141,855
Retained earnings	136,937	135,268
Treasury stock, at cost – 75,022 and 60,432 shares at March 31, 2015 and December 31, 2014, respectively	-753	-595
Accumulated other comprehensive loss	-12,370	-10,856
Total stockholders’ equity	267,419	265,882
Total liabilities and stockholders’ equity	$383,553	$380,115

Unaudited_Condensed_Consolidat1

Unaudited Condensed Consolidated Balance Sheet (Parentheticals) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Preferred stock par value (in Dollars per share)	$0.01	$0.01
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Common Stock, par value (in Dollars per share)	$0.01	$0.01
Common Stock, shares authorized	80,000,000	80,000,000
Common Stock, shares issued	21,793,094	21,587,751
Common Stock, shares outstanding	21,718,072	21,527,319
Treasury stock, shares	75,022	60,432

Unaudited_Condensed_Consolidat2

Unaudited Condensed Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2015		Mar. 31, 2014
Revenues	$71,623	[1]	$63,500	[2]
Cost of sales	56,828		43,007
Gross profit	14,795		20,493
Selling, general, and administrative expense	9,416		6,093
Research and development expense	774		484
Loss related to plant closure	638		1,323
Loss (gain) on disposal of assets	307		247
Operating income	3,660		12,346
Interest income	4		8
Interest expense	-362		-247
Loss on foreign currency	-545
Other expense, net	-110		-56
Income before income taxes	2,647		12,051
Provision for income taxes	978		4,080
Net income	1,669		7,971
Foreign currency translation adjustment net of tax benefit of $886 and $0, respectively	-1,645
Energy swap adjustment, net of tax benefit of $34 and $10, respectively espectively	-64		-18
Pension benefits adjustment, net of tax expense of $105 and $80, respectively	195		149
Comprehensive income	$155		$8,102
Basic earnings per share (See Note 13) (in Dollars per share)	$0.08		$0.38
Weighted average common shares outstanding (in Shares)	21,006		20,355
Diluted earnings per share (See Note 13) (in Dollars per share)	$0.08		$0.37
Weighted average common shares and potential common share equivalents outstanding (in Shares)	21,466		21,014
[1]	Excludes revenue from internal customers of $0.4 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment atcost.
[2]	Excludes revenue from internal customers of $0.7 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment atcost.

Unaudited_Condensed_Consolidat3

Unaudited Condensed Consolidated Statements of Comprehensive Income (Parentheticals) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Foreign currency translation adjustment, tax benefit	$886	$0
Energy swap adjustment, tax benefit	34	10
Pension benefits adjustment, tax expense	$105	$80

Unaudited_Condensed_Consolidat4

Unaudited Condensed Consolidated Statement of Cash Flows (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities:
Net income	$1,669	$7,971
Depreciation and amortization	5,878	5,217
Loss related to plant closure		231
Loss (gain) on disposal of assets	307	247
Provisions for losses on receivables	12	12
Share based compensation	546	392
Deferred income taxes	-525	285
Unrealized loss on foreign currency fluctuations, net	545
Changes in assets and liabilities:
Receivables	-5,855	-6,952
Inventories	3,477	12,716
Prepaid expenses and other current assets	465	1,592
Other assets	-215	-135
Accounts payable	-2,456	-775
Accrued liabilities	-453	434
Pension liability, net	-212	-172
Other long term liabilities	614	-28
Net cash provided by operating activities	3,797	21,035
Cash flows from investing activities:
Proceeds from disposition of assets	15	61
Capital expenditures	-10,560	-12,815
Net cash used in investing activities	-10,545	-12,754
Cash flows from financing activities:
Principal payments of long-term debt	-3,133	-1,219
Proceeds from long-term debt	7,838
Purchase treasury stock at cost	-158	-57
Proceeds from stock options exercised	843	93
Excess tax benefit of stock options exercised	151	9
Net cash provided by (used in) financing activities	5,541	-1,174
Net increase (decrease) in cash and cash equivalents	-1,207	7,107
Cash and cash equivalents at beginning of year	1,430	34,059
Cash and cash equivalents at end of period	$223	$41,166

Note_1_Significant_Accounting_

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	NOTE 1.	SIGNIFICANT ACCOUNTING POLICIES
	SUMMARY OF OPERATIONS AND BASIS OF PRESENTATION
	Business Description
	Omega Protein Corporation (the “Company”) is a nutritional product company that develops, produces and delivers healthy products throughout the world to improve the nutritional integrity of foods, dietary supplements and animal feeds. The Company operates through two industry segments: animal nutrition and human nutrition.
	The animal nutrition segment is comprised primarily of two subsidiaries: Omega Protein, Inc. (“Omega Protein”) and Omega Shipyard, Inc. (“Omega Shipyard”). Omega Protein, the Company’s principal operating subsidiary, is the successor to a business conducted since 1913. Omega Protein produces and markets a variety of products produced from menhaden (a herring-like species of fish found in commercial quantities in the U.S. coastal waters of the Atlantic Ocean and Gulf of Mexico), including regular grade and value-added specialty fish meals, crude and refined fish oils and fish solubles. Omega Protein’s fish meal products are primarily used as a protein ingredient in animal feed for swine, aquaculture and household pets. Fish oil is utilized primarily for animal and aquaculture feeds, as well as additives to human food products and dietary supplements. Omega Protein’s fish solubles are sold primarily to livestock feed manufacturers, aquaculture feed manufacturers and for use as an organic fertilizer. Omega Protein’s business is seasonal in nature and generally has higher revenues during the third quarter of each fiscal year. A portion of Omega Protein’s production is transferred to the human nutrition segment where it is further processed and sold. Omega Shipyard owns and operates a drydock facility in Moss Point, Mississippi that is used to provide shoreside maintenance for Omega Protein’s fishing fleet and, subject to outside demand and excess capacity, occasionally for third-party vessels.
	The human nutrition segment, which operates under the names Nutegrity and Bioriginal, has three primary product lines: protein products, specialty oils and essential fatty acids and other nutraceutical ingredients. Nutegrity is comprised primarily of three subsidiaries: Cyvex Nutrition, Inc. (“Cyvex”), InCon Processing, L.L.C. (“InCon”) and Wisconsin Specialty Protein, L.L.C. (“WSP”). Cyvex, acquired by the Company in December 2010, is located in Irvine, California and is an ingredient provider in the nutraceutical industry. InCon, acquired by the Company in September 2011, is located in Batavia, Illinois and is a specialty processor that utilizes molecular distillation technology to concentrate Omega-3 fish oils and, subject to outside demand and excess capacity, a variety of other compound products for third-party tolling customers. WSP, acquired by the Company in February 2013, is a manufacturer and marketer of specialty dairy proteins and other related products headquartered in Madison, Wisconsin and operates a production facility in Reedsburg, Wisconsin.
	Bioriginal Food & Science Corp. (“Bioriginal”), acquired by the Company in September 2014 and headquartered in Saskatoon, Canada with additional operations in the Netherlands, is a supplier of plant and marine based specialty oils and essential fatty acids to the food and nutraceutical industries. See Note 2 – Acquisition of Bioriginal Food & Science Corp. for additional information related to the Company’s acquisition of Bioriginal.
	Basis of Presentation
	These interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, the instructions to Quarterly Report on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, certain information and footnote disclosures normally provided have been omitted. The interim financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2014. The year end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.
	In the opinion of management the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the Company’s consolidated financial position as of March 31, 2015, and the results of its operations for the three month periods ended March 31, 2015 and 2014 and its cash flows for the three month periods ended March 31, 2015 and 2014. Quarterly operating results are not necessarily indicative of the results that may be expected for the year ending December 31, 2015.
	Consolidation
	The consolidated financial statements include the accounts of Omega Protein Corporation and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.
	Financial Statement Preparation
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Company’s financial statements and the accompanying notes and the reported amounts of revenues and expenses during the reporting period. Actual amounts, when available, could differ from those estimates and those differences could have a material effect on the financial statements.
	As of December 31, 2014, the Company revised the unaudited consolidated balance sheet to correct for the classification of $0.4 million of accounts payable to other long-term liabilities.  This revision was not considered to be material, individually or in the aggregate, to previously issued financial statements. The revisions had no effect on the results of operations (net or comprehensive income) or financial condition (stockholders’ equity).
	Revenue Recognition
	The Company derives revenue principally from the sales of a variety of protein and oil products derived from menhaden. In addition and as a result of its acquisitions of Cyvex, InCon, WSP and Bioriginal the Company’s revenues include sales of dietary supplement and food ingredients and products. The Company recognizes revenue for the sale of its products when price is established, collectability is reasonably assured and risk and rewards of ownership of its products and title are transferred to the customer.
	Shipping and Handling
	Amounts billed to customers associated with shipping and handling are included in revenues and the related costs are included in cost of sales.
	Inventories
	During the off-seasons, in connection with the upcoming fishing seasons, Omega Protein incurs costs (e.g., plant and vessel related labor, utilities, rent, repairs, and depreciation) that are directly related to Omega Protein’s infrastructure. These costs accumulate in inventory and are applied as elements of the cost of production of Omega Protein’s products throughout the fishing season ratably based on Omega Protein’s monthly units of production and the expected total units of production for the season.
	Any costs incurred during abnormal downtime related to activity at Omega Protein’s plants are charged to expense as incurred.
	Energy Swap Agreements
	The Company does not enter into financial instruments for trading or speculative purposes. Omega Protein entered into energy swap agreements to manage portions of its cash flow exposure related to the volatility of natural gas, diesel and fuel oil energy prices for its fish meal and fish oil production operations. The swaps effectively fix pricing for the quantities listed below during the consumption periods. The fair values of outstanding derivative instruments are summarized as follows:
	Energy Swap		Consumption Period				Quantity				Price Per Unit				Energy Swap Asset/(Liability) as of				Deferred Tax Asset/(Liability) as of
															31-Mar-15				31-Mar-15
															(in thousands)
	Diesel - NYMEX Heating Oil Swap		May - November, 2015				3,038,978 Gallons				$	2.53			$	(2,350	)		$	822
	Natural Gas - NYMEX Natural Gas Swap		April – October, 2015				187,575 MMBTUs				$	3.67				(175	)			61
	Propane – Natural Gas Liquids Swap		June - November, 2015				1,024,800 Gallons				$	0.86				(336	)			118
	Diesel - NYMEX Heating Oil Swap		May - November, 2016				2,050,679 Gallons				$	2.3				(833	)			292
	Natural Gas - NYMEX Natural Gas Swap		April – October, 2016				125,000 MMBTUs				$	3.35				(37	)			13
	Propane – Natural Gas Liquids Swap		June - November, 2016				1,355,000 Gallons				$	0.58				(47	)			16
															$	(3,778	)		$	1,322
	Energy Swap		Consumption Period				Quantity				Price Per Unit				Energy Swap Asset/(Liability) as of				Deferred Tax Asset/(Liability) as of
															31-Dec-14				31-Dec-14
															(in thousands)
	Diesel - NYMEX Heating Oil Swap		May - November, 2015				2,333,848 Gallons				$	2.75			$	(2,097	)		$	734
	Natural Gas - NYMEX Natural Gas Swap		April – October, 2015				114,000 MMBTUs				$	4.09				(125	)			44
	Propane – Natural Gas Liquids Swap		June - November, 2015				1,024,800 Gallons				$	0.86				(346	)			121
	Diesel - NYMEX Heating Oil Swap		May - November, 2016				1,333,464 Gallons				$	2.5				(679	)			238
	Propane – Natural Gas Liquids Swap		June - November, 2016				341,600 Gallons				$	0.67				(41	)			14
															$	(3,288	)		$	1,151
	As of March 31, 2015, Omega Protein has recorded a long-term liability of $0.9 million, net of the current portion included in other current liabilities of $2.9 million, to recognize the fair value of energy swap derivatives, and has also recorded a deferred tax asset of $1.3 million associated therewith. As of December 31, 2014, Omega Protein has recorded a long-term liability of $0.7 million net of the current portion included in other current liabilities of $2.6 million to recognize the fair value of energy swap derivatives, and has also recorded a deferred tax asset of $1.2 million associated therewith. The effective portion of the change in fair value from inception to March 31, 2015 is recorded in “accumulated other comprehensive loss” in the Company’s unaudited condensed consolidated financial statements. The following table illustrates the changes recorded, net of tax, in accumulated other comprehensive loss resulting from the energy swap agreements.
			(in thousands)
			2015				2014
	Balance at January 1,		$	(2,137	)		$	179
	Net change associated with current period swap transactions, net of tax,			(64	)			(18	)
	Balance at March 31,		$	(2,201	)		$	161
	The $2.2 million reported in accumulated other comprehensive loss as of March 31, 2015 will be reclassified to the unallocated inventory cost pool in the period when the energy consumption takes place. The amount to be reclassified, net of taxes, during the next 12 months is expected to be approximately $1.7 million.
	The aggregate fair value of derivative instruments in gross liability positions as of March 31, 2015 and December 31, 2014 was $3.8 million and $3.3 million, respectively. These amounts represent the maximum exposure to loss at the reporting date as a result of all of the counterparties failing to perform as contracted.
	As of March 31, 2015 (in thousands)		Gross Amounts of Recognized Assets (Liabilities)				Gross				Net Amounts of Assets (Liabilities) Presented in the Balance Sheet
							Amounts of
							Assets
							(Liabilities)
							Offset
	Energy swap derivatives – liability position		$	(3,811	)		$	33			$	(3,778	)
	As of December 31, 2014 (in thousands)		Gross Amounts of Recognized Assets (Liabilities)				Gross				Net Amounts of Assets (Liabilities) Presented in the Balance Sheet
							Amounts of
							Assets
							(Liabilities)
							Offset
	Energy swap derivatives – liability position		$	(3,288	)		$	-			$	(3,288	)
	If, at any time, the swaps are determined to be ineffective due to changes in the Company’s energy usage or underlying hedge agreements or assumptions, the fair value of the portion of the energy swaps determined to be ineffective will be recognized as a gain or loss in cost of sales for the applicable period. For the three months ended March 31, 2015 and 2014, the Company recognized a charge of $0.4 million and $0, respectively, to cost of sales resulting from transactions associated with the ineffectiveness of diesel energy swaps. The fair value of all outstanding derivatives is determined using a model with inputs that are observable in the market or can be derived from or corroborated by observable data (level 2).
Plant Closure
Property, plant and equipment impairments related to the closure of Cameron, Louisiana plant are made in accordance with the impairment of long-lived assets policy. Employee severance related charges have been recognized to the extent that the amount is probable, measurable and no-future service is expected or for those still employed, recognized pro-rata over the remaining service period. Ongoing clean-up and dismantlement costs will be recognized as incurred unless obligated and measureable by a contractual commitment. See Note 3 – Plant Closure for additional information related to the charges incurred.
Acquisitions, Goodwill and Other Intangible Assets
All of the Company’s goodwill and other intangible assets are the result of acquisitions in the human nutrition segment. This segment is comprised of three reporting units, 1) InCon and Cyvex, 2) WSP and 3) Bioriginal. The Company has recorded goodwill and certain other identifiable intangible assets that are more fully explained in Note 2 – Acquisition of Bioriginal Food & Science Corp. and Note 9 – Goodwill and Other Intangible Assets.
Accumulated Other Comprehensive Loss
The components of accumulated other comprehensive (loss) gain, net of tax, included in stockholders’ equity are as follows:
Changes in Accumulated Other Comprehensive Loss by Component
For the Three Months Ended March 31, 2015 (in thousands)
		Gains and Losses					Defined Benefit					Foreign currency				Total
		On Cash Flow					Pension Items					Translation
		Hedges										adjustment
Balance as of December 31, 2014		$	(2,137	)			$	(7,804	)			$	(915	)		$	(10,856	)
Other comprehensive loss before reclassifications			(64	)				—					(1,645	)			(1,709	)
Amounts reclassified from accumulated other comprehensive loss			—		(a)			195		(b)			—				195
Net current-period other comprehensive income			(64	)				195					(1,645	)			(1,514	)
Balance as of March 31, 2015		$	(2,201	)			$	(7,609	)			$	(2,560	)		$	(12,370	)
		Gains and Losses					Defined Benefit					Total
		On Cash Flow					Pension Items
		Hedges
Balance as of December 31, 2013		$	179				$	(6,387	)			$	(6,208	)
Other comprehensive loss before reclassifications			(18	)				—					(18	)
Amounts reclassified from accumulated other comprehensive loss			—		(a)			149		(b)			149
Net current-period other comprehensive income			(18	)				149					131
Balance as of March 31, 2014		$	161				$	(6,238	)			$	(6,077	)
	(b)	This accumulated other comprehensive income component is included in the computation of net periodic pension costs as amortization of actuarial loss which are explained in more detail in Note 15 to the consolidated financial statements in Item 8 of the Company’s Form 10-K for the fiscal year ended December 31, 2014.
Recently Issued Accounting Standards
In April 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2015-03, Interest- Imputation of Interest (Subtopic 835-30).  The amendments require that debt issuance costs related to recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debit issuance costs are not affected by the amendments in this update. The new standard is effective in annual periods beginning after December 15, 2015 and interim periods within those annual periods. Early adoption is permitted. The Company’s adoption of FASB ASU No. 2015-03 is not expected to have a material impact on the Company’s consolidated results of operations, financial position and related disclosures.
In February 2015, the FASB issued ASU 2015-02, Consolidation (Topic 810).  The amendments (1) modify the evaluation of whether limited partnerships and similar legal entities are variable interest entities (VIEs) or voting interest entities, (2) eliminate the presumption that a general partner should consolidate a limited partnership, (3) affect the consolidation analysis of reporting entities that are involved with VIEs, particularly those that have fee arrangements and related party relationships (4) provide a scope exception from consolidation guidance for reporting entities with interest in legal entities that are required to comply with or operate in accordance with requirements that are similar to those in Rule 2a-7 of the Investment Company Act of 1940 for registered money market funds. The new standard is effective in annual periods beginning after December 15, 2015 and interim periods within those annual periods. Early adoption is permitted. The Company’s adoption of FASB ASU No. 2015-02 is not expected to have an impact on the Company’s consolidated results of operations, financial position and related disclosures.
In January 2015, the FASB issued ASU 2015-01, Income Statement- Extraordinary and Unusual Items (Subtopic 225-20).  The update eliminates from GAAP the concept of extraordinary items. Eliminating the concept of extraordinary items will save time and reduce costs for preparers because they will not have to assess whether a particular event or transaction event is extraordinary. This alleviates uncertainty for preparers, auditors, and regulators because auditors and regulators no longer will need to evaluate whether a preparer treated an unusual and/or infrequent item appropriately. The new standard is effective in annual periods beginning after December 15, 2015 and interim periods within those annual periods. Early adoption is permitted. The Company’s adoption of FASB ASU No. 2015-01 is not expected to have an impact on the Company’s consolidated results of operations, financial position and related disclosures.
In November 2014, the FASB issued ASU 2014-16, Derivatives and Hedging: Determining whether the Host Contract in a Hybrid Financial Statement Issued in the Form of a Share is More Akin to Debt or Equity.  This ASU amended the Derivatives and Hedging Accounting Standards Codification to eliminate the use of different methods in practice and thereby reduce existing diversity under GAAP in the accounting for hybrid financial instruments used in the form of a share. The new standard is effective in annual periods beginning on or after December 15, 2015 with early adoption permitted. The Company’s adoption of FASB ASU No. 2014-16 is not expected to have an impact on the Company’s consolidated results of operations, financial position and related disclosures.
In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements- Going Concern (Subtopic 205-40). The amendments require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in the U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The guidance is effective for annual periods ending after December 15, 2016 and for annual periods thereafter. Early adoption is permitted.  The Company does not expect this ASU to have a material impact on the Company’s consolidated results of operations, financial position and related disclosures.
In June 2014, the FASB issued ASU No. 2014-12, Compensation — Stock Compensation (Topic 718), Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period.  A performance target in a share-based payment that affects vesting and that could be achieved after the requisite service period should be accounted for as a performance condition under Accounting Standards Codification (ASC) 718, Compensation — Stock Compensation. As a result, the target is not reflected in the estimation of the award's grant date fair value. Compensation cost would be recognized over the required service period, if it is probable that the performance condition will be achieved.  The guidance is effective for annual periods beginning after December 15, 2015 and interim periods within those annual periods. Early adoption is permitted.  The Company does not expect this ASU to have a material impact on the Company’s consolidated results of operations, financial position and related disclosures.
In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers.  This ASU amends the existing accounting standards for revenue recognition and is based on the principle that revenue should be recognized to depict the transfer of goods or services to a customer at an amount that reflects the consideration a company expects to receive in exchange for those goods or services.  The guidance is effective for annual periods beginning after December 15, 2017 and interim periods within those annual periods. The Company is currently evaluating the potential impact of these changes on the consolidated results of operations, financial position and related disclosures.
In April 2014, the FASB issued ASU No. 2014-08, Presentation of Financial Statements and Property, Plant and Equipment: Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. This ASU changes the criteria for determining which disposals can be presented as discontinued operations and modifies related disclosure requirements. Under the new guidance, a discontinued operation is defined as a disposal of a component or group of components that is disposed of or is classified as held for sale and represents a strategic shift that has or will have a major effect on an entity's operations and financial results. The new standard is effective in annual periods beginning on or after December 15, 2014 with early adoption permitted. The guidance applies prospectively to new disposals and new classifications of disposal groups as held for sale after the effective date. The Company’s adoption of FASB ASU No. 2014-08 effective January 1, 2015 did not have an impact on the Company’s consolidated results of operations, financial position and related disclosures.
Foreign Currency Translations
All amounts are expressed in U.S. dollars unless otherwise indicated. The U.S. dollar is the functional currency of Bioriginal’s Canadian-based subsidiaries (“Bioriginal Canada”). Monetary assets and liabilities denominated in foreign currencies are translated into U.S. dollars at exchange rates in effect at the balance sheet date. Non-monetary items are translated at rates of exchange in effect when the assets were acquired or obligations incurred. Revenue and expenses are translated at average rates in effect in the period of the transaction. Foreign exchange gains and losses are included in the unaudited condensed consolidated statement of comprehensive income.
The Euro is the functional currency of Bioriginal’s Netherlands-based subsidiaries (“Bioriginal Europe”). The operations of these subsidiaries are considered self-sustaining and their financial statements are translated into U.S. dollars using the current rate method. Under this method, all assets and liabilities are translated to U.S. dollars at exchange rates in effect at the balance sheet date and all revenue and expenses are translated at rates in effect at the time of the transactions. Exchange gains and losses arising from this translation, representing the net unrealized foreign currency translation gain (loss) on the Company's net investment in its self-sustaining subsidiaries, are recorded in the accumulated other comprehensive income (loss) component of shareholders' equity. Adjustments to the accumulated other comprehensive income (loss) account are not recorded in the unaudited condensed consolidated statement of comprehensive income until realized through a reduction in the Company's net investment in such operations.
Stock-Based Compensation
Stock Options
The Company has issued non-qualified stock options under its incentive plans. The options generally vested in equal installments over three years and expire in ten years. As of and for the quarters ended March 31, 2015 and 2014, all stock options were vested and no stock-based compensation costs related to stock options was incurred.
Restricted Stock
The Company has issued shares of restricted stock under the 2006 Incentive Plan. Shares of restricted stock have generally vested on the third anniversary of the grant date or in equal installments over three years except for shares of restricted stock granted to non-employee directors which vest six months after the grant date. Non-vested shares are generally forfeited upon the termination of employment or service as a director. Holders of shares of restricted stock are entitled to all rights of a stockholder of the Company, including the right to vote the shares and receive any dividends or other distributions. The non-vested shares are considered participating securities and the Company has calculated earnings per share using the two-class method. See Note 12 – Reconciliation of Basic and Diluted Per Share Data.
During the three month periods ended March 31, 2015 and 2014, the Company issued 82,072 and 92,545 shares of restricted stock, respectively, under the 2006 Incentive Plan to employees and non-employee directors. The Company’s compensation expense related to restricted stock was approximately $0.5 million and $0.3 million ($0.4 million and $0.2 million after tax) for the three months ended March 31, 2015 and 2014, respectively, which is primarily reflected in selling, general and administrative expenses in the unaudited condensed consolidated statement of comprehensive income. As of March 31, 2015, there was approximately $4.3 million ($2.8 million after tax) of unrecognized compensation expense related to non-vested restricted stock that is expected to be recognized over a weighted-average period of 1.6 years, of which $1.5 million ($0.9 million after-tax) of compensation expense is expected to be recognized during the remainder of fiscal year 2015.
Performance Units
On February 6, 2014, the Company adopted the 2014 Cash Incentive Performance Unit Plan and on February 26, 2015, the Company adopted the 2015 Cash Incentive Performance Unit Plan. The value of the units under the plans will be determined by reference to the performance of the Company’s common stock during the relevant performance period compared to the performance of the Russell 2000 Index member companies (the “Peer Group”) during that same period. One third of the Performance Units granted will be earned at the end of each calendar year of the performance period and will be valued for the calendar year based on the Total Shareholder Return (“TSR”) of the Company compared to the TSR of the Peer Group. The performance units contain a service provision of approximately 3 years and are liability-classified awards included in other long-term liabilities which are adjusted to fair value on a quarterly basis.
The Company’s compensation expense related to performance units was approximately $0.3 million and $0.1 million ($0.2 million and $0.1 million after tax) for the three months ended March 31, 2015 and 2014, respectively, which is primarily reflected in selling, general and administrative expenses in the unaudited condensed consolidated statement of comprehensive income. As of March 31, 2015, there was approximately $2.7 million ($1.7 million after tax) of unrecognized compensation expense related to performance units that is expected to be recognized over a weighted-average period of 2.5 years, of which $0.8 million ($0.5 million after-tax) of compensation expense is expected to be recognized during the remainder of fiscal year 2015.

Note_2_Acquisition_of_Biorigin

Note 2 - Acquisition of Bioriginal Food & Science Corp. (Bioriginal [Member])	3 Months Ended
	Mar. 31, 2015
Bioriginal [Member]
Note 2 - Acquisition of Bioriginal Food & Science Corp. [Line Items]
Mergers, Acquisitions and Dispositions Disclosures [Text Block]	NOTE 2. ACQUISITION OF BIORIGINAL FOOD & SCIENCE CORP.
	A. Description of the Transaction
	In September 2014, the Company acquired all of the issued and outstanding equity of Bioriginal pursuant to the terms of a Share Purchase Agreement (“Purchase Agreement”) and Bioriginal became a wholly owned subsidiary of the Company.  Bioriginal is a leading supplier of plant and marine based specialty oils and essential fatty acids to the food and nutraceutical industries across North America, Europe and Asia. Bioriginal is included as part of the Company’s human nutrition segment.
	B. Recording of Assets Acquired and Liabilities Assumed
	In connection with its acquisition of Bioriginal, the Company paid an aggregate purchase price of $70.5 million, plus an estimated working capital adjustment of $0.7 million, to the sellers as follows: (i) $46.5 million in cash to the sellers, (ii) assumption of approximately $21.5 million of Bioriginal’s indebtedness, and (iii) issuance of 238,377 shares of restricted common stock of the Company valued at approximately $3.2 million (based on a 30-day average closing price) to certain sellers (the “Management Sellers”). The restrictions on the shares will terminate, with certain exceptions, on the third anniversary of the closing date and are subject to the terms and conditions of the Purchase Agreement; see Note - 1 Significant Accounting Policies Summary of Operations and Basis of Presentation for more information on Restricted Stock. The Purchase Agreement also provides for a performance-based earn-out amount of up to a maximum that, as of December 31, 2014, was $7.1 million Canadian dollars to be paid in September 2017 to the Management Sellers for achieving or exceeding certain adjusted EBITDA targets for Bioriginal during calendar years 2014 through 2016; see Note 12 Commitments and Contingencies for additional information. During the three months ended March 31, 2015, the Company received $0.1 million related to the finalization of the closing working capital adjustment.
	The Company incurred approximately $2.8 million in pretax transaction costs directly related to the acquisition that were expensed and included in selling, general and administrative expenses in the consolidated statement of comprehensive income for the year ended December 31, 2014. The acquisition costs consisted primarily of legal, advisory, valuation, and other consulting fees. The transaction has been accounted for using the acquisition method of accounting which requires, among other things, that all assets acquired and liabilities assumed from acquisitions be recognized at their fair values as of the acquisition date. Any excess of the purchase price over the fair values of the net assets acquired are recorded as goodwill. The following table shows the allocation of the purchase price:
	Cash		$	93
	Accounts receivable			15,072
	Inventories			20,309
	Other current assets, net including prepaid expenses			1,820
	Property, plant, and equipment			3,026
	Identifiable intangible assets (a)			16,987
	Liabilities assumed			(38,288	)
	Total identifiable net assets			19,019
	Goodwill			27,462
	Total consideration		$	46,481
		(a)	See Note 9 – Goodwill and Other Intangible Assets for weighted average lives.
	Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Specifically, the goodwill recorded as part of the acquisition of Bioriginal includes the following:
	● the expected synergies and other benefits that the Company believes may result from combining the operations of Bioriginal with the operations of the Company’s human nutrition segment,
	● any intangible assets that do not qualify for separate recognition, and
	● the value of the going-concern element of Bioriginal’s existing business (the higher rate of return on the assembled collection of net assets versus if the Company had acquired all of the net assets separately).
	See Note 9 - Goodwill and Other Intangible Assets, for more information about goodwill and other intangible assets.
	C. Unaudited Pro Forma Financial Information
	The unaudited financial information in the table below summarizes the combined results of operations of the Company and Biorginial on a pro forma basis, as though the companies had been combined as of January 1, 2014. The pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had actually taken place on January 1, 2014 and is not intended to be a projection of future results or trends.
			Revenue			Net income
			(in thousands)
	2014 supplemental pro forma from January 1, 2014 – March 31, 2014		$	89,409		$	8,890

Note_3_Plant_Closure

Note 3 - Plant Closure	3 Months Ended
	Mar. 31, 2015
Disposal Groups Plant Closure Disclsoure [Abstract]
Disposal Groups Plant Closure Disclsoure [Text Block]	NOTE 3. PLANT CLOSURE
	In December 2013, the Company effectively closed its menhaden fish processing plant located in Cameron, Louisiana and re-deployed certain vessels from that facility to the Company’s other Gulf Coast facilities located in Abbeville, Louisiana and Moss Point, Mississippi. In conjunction with the closure, the following charges were incurred in the Company’s unaudited condensed consolidated statements of comprehensive income for the three months ended March 31, 2015 and from December 2013 to March 31, 2015:
		Three Months Ended		December 2013 to March 31, 2015
		31-Mar-15
		(in thousands)
	Impairment of property, plant and equipment	$	—	$	7,922
	Write-off material and supplies inventory		—		150
	Employee severance costs		—		732
	Estimated decommissioning costs		—		250
	Other ongoing closure costs not attributable to future production		638		5,238
	Total loss related to plant closure	$	638	$	14,292
	In addition to the above recognized losses, the Company expects that it may have additional losses related to ongoing costs not attributable to future production such as site costs, clean-up and disassembly.

Note_4_Receivables_Net

Note 4 - Receivables, Net	3 Months Ended
	Mar. 31, 2015
Receivables [Abstract]
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	NOTE 4. RECEIVABLES, NET
	Receivables are summarized as follows:
		March 31,			December 31,
		2015			2014
		(in thousands)
	Trade	$	35,742		$	29,534
	Insurance		1,276			1,711
	Income tax		5,205			5,442
	Other		134			370
	Total accounts receivable		42,357			37,057
	Less allowance for doubtful accounts		(403	)		(436	)
	Receivables, net	$	41,954		$	36,621

Note_5_Inventory

Note 5 - Inventory	3 Months Ended
	Mar. 31, 2015
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	NOTE 5. INVENTORY
	The major classes of inventory are summarized as follows:
		March 31,		December 31,		March 31,
		2015		2014		2014
		(in thousands)
	Fish meal	$	9,343	$	28,400	$	14,988
	Fish oil		15,155		19,300		24,194
	Fish solubles		301		683		1,763
	Nutraceutical products		5,212		4,635		4,299
	Bioriginal products		24,708		26,219		—
	Dairy protein products		2,955		2,783		1,442
	Unallocated inventory cost pool (including off-season costs)		26,707		6,854		25,900
	Other materials and supplies		9,170		8,639		8,829
	Total inventory	$	93,551	$	97,513	$	81,415
	Inventory at March 31, 2015, December 31, 2014 and March 31, 2014 is stated at the lower of cost or market. The elements of the March 31, 2015 unallocated inventory cost pool include Omega Protein’s plant and vessel related labor, utilities, rent, repairs and depreciation, which are allocated to 2015 fishing season production.

Note_6_Prepaid_Expenses_and_Ot

Note 6 - Prepaid Expenses and Other Current Assets	3 Months Ended
	Mar. 31, 2015
Disclosure Text Block Supplement [Abstract]
Other Current Assets [Text Block]	NOTE 6. PREPAID EXPENSES AND OTHER CURRENT ASSETS
	Prepaid expenses and other current assets are summarized below:
		March 31,		December 31,
		2015		2014
		(in thousands)
	Prepaid insurance	$	1,348	$	2,322
	Product deposits		818		998
	Design expenses		353		331
	Selling expenses		79		156
	Fair value of derivative instruments - energy swaps, current portion		15		—
	Leases		189		168
	Other prepaids and expenses		1,281		961
	Total prepaid expenses and other current assets	$	4,083	$	4,936
	Amounts included in prepaid expenses and other current assets consist primarily of prepaid operating expenses including insurance, rents, and selling expenses. Prepaid selling expenses are expensed in those periods in which the related revenue is recognized.

Note_7_Other_Assets

Note 7 - Other Assets	3 Months Ended
	Mar. 31, 2015
Disclosure Text Block Supplement [Abstract]
Other Assets Disclosure [Text Block]	NOTE 7. OTHER ASSETS
	Other assets are summarized as follows:
		March 31,		December 31,
		2015		2014
		(in thousands)
	Fish nets, net of accumulated amortization of $3,012 and $2,694	$	881	$	1,195
	Insurance receivable		710		498
	Title XI debt issuance costs		238		246
	Other debt issuance costs		241		264
	Deposits and other		106		106
	Total other assets, net	$	2,176	$	2,309
	Amortization expense for fishing nets amounted to approximately $0.3 million for each of the three months ended March 31, 2015 and 2014.
	As of March 31, 2015 and December 31, 2014, insurance receivables primarily relates to Jones Act claims for employees aboard its vessels. This estimated amount is recorded gross of estimated claims which may be due to claimants and is included in accrued insurance liabilities.
	The Company carries insurance for certain losses relating to its fishing vessels and Jones Act liability for employees aboard its vessels (collectively, “Vessel Claims Insurance”). The typical Vessel Claims Insurance policy contains an annual aggregate deductible (“AAD”) for which Omega Protein remains responsible, while the insurance carrier is responsible for all applicable amounts which exceed the AAD. It is Omega Protein’s policy to accrue current amounts due and record amounts paid out on each claim. Once payments exceed the AAD, Omega Protein records an insurance receivable for a given policy year.

Note_8_Property_Plant_and_Equi

Note 8 - Property, Plant, and Equipment	3 Months Ended
	Mar. 31, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	NOTE 8. PROPERTY, PLANT AND EQUIPMENT
	Property, plant and equipment are summarized as follows:
		March 31,			December 31,
		2015			2014
		(in thousands)
	Land	$	9,356		$	9,326
	Plant assets		189,043			188,498
	Fishing vessels		110,397			111,379
	Furniture and fixtures		7,822			7,792
	Construction in progress		26,070			15,893
	Total property and equipment		342,688			332,888
	Less accumulated depreciation and impairment		(167,109	)		(162,956	)
	Property, plant and equipment, net	$	175,579		$	169,932
	Depreciation expense for the three months ended March 31, 2015 and 2014 was $5.1 million and $4.7 million, respectively.
	The Company capitalizes interest as part of the acquisition cost of a qualifying asset. Interest is capitalized only during the period of time required to complete and prepare the asset for its intended use. For each of the three month periods ended March 31, 2015 and 2014, the Company capitalized interest of approximately $0.2 million.

Note_9_Goodwill_and_Other_Inta

Note 9 - Goodwill and Other Intangible Assets	3 Months Ended
	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets Disclosure [Text Block]	NOTE 9. GOODWILL AND OTHER INTANGIBLE ASSETS
	Goodwill is measured as the excess of the cost of an acquisition over the sum of the amounts assigned to the fair value of tangible and intangible assets acquired less liabilities assumed. All of the Company’s goodwill and other intangible assets are the result of acquisitions in the human nutrition segment.
	Goodwill is tested annually for impairment of value, and whenever an event occurs or circumstances change that would more likely than not indicate the carrying amount of the asset is impaired. Determining whether an indicator of impairment has occurred during an interim period involves a significant amount of judgment.  During the interim periods, qualitative factors such as deterioration in general economic conditions, changes in the market for an entity’s products or services, declines in actual or planned revenue or earnings compared with actual and projected results of relevant prior periods, among others, are evaluated to determine if a triggering event which would result in a potential impairment has incurred.
	As of December 31, 2014, the carrying value of InCon and Cyvex’s trade secrets and goodwill exceeded its calculated fair values by $0.6 million and $4.1 million, respectively, due primarily to recent operating results and the Company revising its forward looking cash flow forecast associated with this reporting unit. Fair value was determined by utilizing market and income approaches. As a result, a $4.7 million impairment expense was recognized during the year ended December 31, 2014. Key assumptions in the fair value calculation include future fish oil and nutraceutical sales volumes and prices, tolling, the portion of sales attributable to trade secrets, production costs and the discount rate.
	As of December 31, 2014, the calculated fair value of WSP’s trade secrets exceeds its $1.1 million carrying value by 100% or more. The calculated fair value of goodwill exceeds its carrying values by less than 1%. Key assumptions in the fair value calculation include dairy protein product sales volumes and prices, the portion of sales attributable to the brand name, the cost of availability of raw materials and the discount rate.
	It should be noted that the assessments of goodwill and indefinitely lived intangible assets are based on assumptions that require speculation and are highly subjective given the early stage and transitional nature of the businesses and the use of other reasonable, but different, assumptions could provide significantly different fair values and potentially impairments. The Company’s annual quantitative tests have assumed increasing cash flows over the next several years, based on anticipated sales growth and improved profitability. Even though for the three months ended March 31, 2015, the InCon and Cyvex reporting unit has not achieved the assumed results by a relatively small margin, the Company’s long-term outlook on these businesses remains consistent with the previous forecast. However, considering the level of sensitivity with respect to the key assumptions, if future cash flow expectations decline sufficiently, the estimated fair values would be reduced and could potentially result in a material impairment in a subsequent period.
	The following table summarizes the changes in the carrying amount of goodwill resulting from the Company’s acquisitions of Bioriginal, WSP, Cyvex and InCon (in thousands):
		Bioriginal			WSP			Cyvex and		Total
								InCon
	1-Jan-15	$	27,045			11,614			3,842	$	42,501
	Foreign currency translation adjustment		(556	)		—			—		(556	)
	31-Mar-15	$	26,489			11,614			3,842	$	41,945
	The following table summarizes the Company’s intangible assets (dollars in thousands):
		March 31,			December 31,			Weighted
		2015			2014			Average
								Life (years)
	Carrying value of intangible assets subject to amortization:
	Customer relationships and non-competes	$	19,625		$	19,625
	Less accumulated amortization		(2,837	)		(2,344	)		10
	Total intangible assets subject to amortization, net	$	16,788		$	17,281
	Foreign currency translation adjustment		(431	)		(191	)
	Total intangible assets subject to foreign current translation adjustment, net	$	16,357		$	17,090
	Indefinite life intangible assets – trade names/secrets and other		5,840			5,912
	Total intangible assets	$	22,197		$	23,002
	Amortization expense of the Company’s intangible assets for the three months ended March 31, 2015 and 2014 was approximately $0.5 million and $0.2 million, respectively. Estimated future amortization expense related to intangible assets is as follows (in thousands):
	Remainder of 2015	$	1,478
	2016		1,971
	2017		1,971
	2018		1,971
	Thereafter		9,397
	Total estimated future amortization expense	$	16,788
	The Company’s goodwill and other intangible assets are more fully explained in Note 10 to the consolidated financial statements in Item 8 of the Company’s Form 10-K for the fiscal year ended December 31, 2014.

Note_10_Notes_Payable_and_Long

Note 10 - Notes Payable and Long-term Debt	3 Months Ended
	Mar. 31, 2015
Disclosure Text Block [Abstract]
Long-term Debt [Text Block]	NOTE 10. NOTES PAYABLE AND LONG-TERM DEBT
	A summary of the Company's long-term debt consisted of the following:
		March 31,			December 31,
		2015			2014
		(in thousands)
	U.S. government guaranteed obligations (Title XI loans) collateralized by a first lien on certain vessels and certain plant assets:
	Amounts due in installments through 2025, interest from 5.7% to 7.0%	$	20,478		$	21,111
	Amounts due on Loan Agreement in March 2017, interest at LIBOR plus an applicable rate (1.90% and 1.84% at March 31, 2015 and December 31, 2014, respectively)		3,500			2,000
	ING Commercial Finance B.V., interest at EURIBOR plus an applicable rate (1.70% and 1.76% at March 31, 2015 and December 31, 2014, respectively)		2,161			2,367
	HSBC credit facility, matures March 2019, interest at HSBC prime rate plus an applicable rate (4.5% at March 31, 2015 and December 31, 2014)		13,536			9,749
	Total debt		39,675			35,227
	Less current maturities		(18,379	)		(14,741	)
	Long-term debt	$	21,296		$	20,486
	The estimated fair value of the Company’s total debt at March 31, 2015 and December 31, 2014, based on quoted market prices available to the Company for issuance of similar debt with similar terms (level 2), was $41.3 million and $36.9 million, respectively.
	The Title XI loans are secured by certain liens on the Company’s fishing vessels and mortgages on the Company’s Reedville, Virginia and Abbeville, Louisiana plants.
	In June 2011, pursuant to the Title XI program, the United States Department of Commerce Fisheries Finance Program (the “FFP”) approved a financing application made by the Company in the amount of $10 million (the “Approval Letter”) which expires on June 20, 2016. To date, the Company has not borrowed any amounts under the Approval Letter and its ability to do so has been adversely affected by an EPA notice that the Company’s Omega Protein subsidiary is ineligible, as a result of its previous convictions under the Clean Water Act, for receipt of government contracts or benefits in certain cases. See “Risk Factors - If our Omega Protein subsidiary fails to comply with the terms of its probation under a plea agreement entered into in June 2013, we could be subject to criminal prosecution” in the Company’s Form 10-K for the year ended December 31, 2014 for further detail on this EPA notice. As of March 31, 2015, the Company had approximately $20.5 million of borrowings outstanding under Title XI and was in compliance with all of the covenants contained therein.
	In March 2012, the Company entered into an Amended and Restated Loan Agreement (the “Loan Agreement”) with Wells Fargo Bank, National Association, as administrative agent (the “Agent”) for the lenders (currently Wells Fargo Bank, National Association and JP Morgan Chase Bank, N.A.) (collectively, the “Lenders”) pursuant to which the Lenders agreed to extend credit to the Company in the form of loans (each a “Loan” and collectively, the “Loans”) on a revolving basis of up to $60 million (the “Commitment”). In September 2014, the Company and the Lenders amended the Loan Agreement to (i) permit the acquisition of Bioriginal by the Company, (ii) permit certain existing indebtedness of Bioriginal and the related liens, (iii) add certain collateral under the Loan Agreement relating to Bioriginal, and (iv) increase the commitment of the Lenders under the Loan Agreement by $10 million to a total of $70 million. The Loan Agreement also requires the Company to comply with various affirmative and negative covenants affecting the Company’s businesses and operations, including various financial covenants.
	All Loans and all other obligations outstanding under the Loan Agreement are payable in full on March 21, 2017. As of March 31, 2015 and December 31, 2014, the Company had $3.5 million outstanding under the Loan Agreement and approximately $3.5 million in letters of credit. As of March 31, 2015, the Company was in compliance with all financial covenants under the Loan Agreement. The Company has no off-balance sheet arrangements other than normal operating leases and standby letters of credit.
	On June 6, 2010, Bioriginal Europe entered into a credit facility with ING Bank N.V. which provides borrowings up to 250,000 Euro.  Under the credit facility, interest is paid at 2.97% plus the EURIBOR rate (currently 2.98%).  The credit facility is secured by Bioriginal Europe’s equipment. The facility contains cross default provisions and other covenants.   As of March 31, 2015, there were no outstanding borrowings under the credit facility.
	In March 2015, Bioriginal Europe extended the terms of its credit facility with ING Commercial Finance B.V. which provides borrowings up to an amount based on accounts receivable and inventory balances, and matures on March 31, 2018.  Advances are repayable on demand and bear interest payable monthly at 1.75% + EURIBOR (currently 1.70%).  The credit facility is secured by accounts receivable and inventory of Bioriginal Europe to a maximum of 85% of accounts receivable and 60% of inventory.  The credit facility contains cross default provisions and other covenants.  As of March 31, 2015, $2.2 million was outstanding under this credit facility, which is included in current maturities.
	On April 15, 2014, Bioriginal Canada entered into a credit facility with HSBC Bank of Canada (the “Bioriginal Credit Facility”) which provides borrowings up to $20 million Canadian dollars and matures on March 15, 2019, subject to HSBC’s right to terminate the facility in its sole discretion. Under the Bioriginal Credit Facility, Bioriginal Canada has an operating line of credit for which interest is paid at HSBC prime rate plus 1.25% (currently 4.5%) and is secured by Bioriginal Canada’s accounts receivable and inventory and is payable on demand. Additionally, there is a separate maximum of $4.2 million related to letters of credit. At March 31, 2015, Bioriginal has issued $4.2 million in letters of credit in support of product purchases from a foreign supplier. Generally these letters of credit are insured by Export Development Canada and are not considered to be drawn under this credit facility. As of March 31, 2015, $13.5 million was outstanding under these subsections of the credit facility, which is included in current maturities.
	The Company’s notes payable and long-term debt are more fully explained in Note 11 to the consolidated financial statements in Item 8 of the Company’s Form 10-K for the fiscal year ended December 31, 2014.

Note_11_Accrued_Liabilities

Note 11 - Accrued Liabilities	3 Months Ended
	Mar. 31, 2015
Disclosure Text Block Supplement [Abstract]
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]	NOTE 11. ACCRUED LIABILITIES
	Accrued liabilities are summarized as follows:
		March 31,		December 31,
		2015		2014
		(in thousands)
	Insurance	$	6,007	$	5,998
	Reserve for plant closure costs		327		456
	Salary and benefits		4,552		7,273
	Trade creditors		7,290		5,045
	Taxes, other than income tax		605		222
	Income tax		701		—
	Energy swap liability, current portion		2,876		2,568
	Deferred revenue		538		1,400
	Accrued interest		244		246
	Other		—		8
	Total accrued liabilities	$	23,140	$	23,216
	Deferred revenue represents payments primarily received from international customers related to revenues which were not recognized until the subsequent period due to revenue recognition criteria.

Note_12_Commitments_and_Contin

Note 12 - Commitments and Contingencies	3 Months Ended
	Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	NOTE 12. COMMITMENTS AND CONTINGENCIES
	Bioriginal Contingency
	In September 2014, the Company acquired all of the outstanding equity of Bioriginal pursuant to the terms of a share purchase agreement. A portion of the equity of Bioriginal was indirectly held by the Management Sellers, who continue to be employed by Bioriginal and share in the management of Bioriginal’s business. Bioriginal is now a wholly owned subsidiary of the Company.
	In addition to the acquisition date cash purchase price and restricted stock, the Management Sellers may also earn additional amounts based on the annual adjusted EBITDA of Bioriginal’s business during each of the calendar years 2014 through 2016. For each calendar year, if the adjusted EBITDA meets or exceeds agreed upon targets for the calendar year, the payout ranging from $1.2 million Canadian dollars to $2.9 million Canadian dollars will be earned, subject to certain forfeitures based on termination of Management Sellers’ employment. The maximum total payment for all three years is $7.1 million Canadian dollars.
	The earn-out payments in Canadian dollars, if any, will be estimated on a quarterly basis and paid in September 2017. The Company will record the estimated contractual obligation as compensation expense during each year as it is deemed probable that such amount will be payable. As of March 31, 2015 and December 31, 2014, the Company recorded a $0.7 million and $0.4 million liability, respectively, related to this provision of the agreement. The threshold for a $1.2 million Canadian payment was achieved for 2014.
	Legal Contingencies
	The Company is subject to various claims and lawsuits involving its business and operations. Management believes that costs, if any, relating to these matters will not have a material adverse effect on the results of operations, cash flows or financial position of the Company.
	Regulatory Matters
	The Company is subject to various possible claims and lawsuits regarding environmental matters. Management believes that costs, if any, related to these matters will not have a material adverse effect on the results of operations, cash flows or financial position of the Company.

Note_13_Reconciliation_of_Basi

Note 13 - Reconciliation of Basic and Diluted Per Share Data	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	NOTE 13. RECONCILIATION OF BASIC AND DILUTED PER SHARE DATA (in thousands except per share date)
	Basic earnings per share is calculated by dividing net income allocated to common shares outstanding by the weighted average number of shares of common stock outstanding. Diluted earnings per share assumes the exercise of stock options provided the effect is not anti-dilutive.
	The Company grants certain incentive compensation awards, including restricted stock, to employees and non-employee directors that are considered to be participating securities. Due to the presence of participating securities, we have calculated our earnings per share using the two-class method.
	Three Months Ended March 31:	2015				2014
	Allocation of earnings:
	Net income	$	1,669			$	7,971
	Income allocated to participating securities		(44	)			(192	)
	Income allocated to common shares outstanding	$	1,625			$	7,779
	Weighted average common shares outstanding		21,006				20,355
	Basic earnings per share				0.08				0.38
	Stock options assumed exercised		460				659
	Weighted average diluted common shares and potential common share equivalents outstanding		21,466				21,014
	Diluted earnings per share				0.08				0.37
	Options to purchase the following number of shares of common stock (in thousands) were outstanding during the three months ended March 31, 2015 and 2014 but were excluded from the computation of diluted earnings per share because the adjusted exercise prices of the options based upon the assumed proceeds were greater than the average market price of the shares during that period.
	Three Months Ended March 31,
	2015	2014
	125	130

Note_14_Components_of_Net_Peri

Note 14 - Components of Net Periodic Benefit Cost	3 Months Ended
	Mar. 31, 2015
Compensation and Retirement Disclosure [Abstract]
Pension and Other Postretirement Benefits Disclosure [Text Block]	NOTE 14. COMPONENTS OF NET PERIODIC BENEFIT COST
		Three Months Ended
		March 31,
		2015			2014
		(in thousands)
	Service cost	$	—		$	—
	Interest cost		230			274
	Expected return on plan assets		(276	)		(298	)
	Amortization of prior service costs		—			—
	Amortization of net loss		300			229
	Net periodic pension cost	$	254		$	205
	For the three months ended March 31, 2015 and 2014, the Company contributed approximately $0.4 million and $0.4 million, respectively, to the Company’s pension plan. The Company expects to make contributions of $0.8 million to the pension plan during the remainder of 2015.
	In 2002, the Board of Directors authorized a plan to freeze the Company’s pension plan in accordance with ERISA rules and regulations so that new employees, after July 31, 2002, are not eligible to participate in the pension plan and further benefits no longer accrue for existing participants.

Note_15_Industry_Segments

Note 15 - Industry Segments	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	NOTE 15. INDUSTRY SEGMENTS
	The Company reports in two segments, animal nutrition and human nutrition. These segments are managed separately and information on each segment is provided to the chief operating decision makers as they make decisions about the Company’s overall resource allocation and assess performance.
	The animal nutrition segment is primarily comprised of the Company’s fishing related assets. These assets produce fish meal, oil and solubles that are sold primarily to animal nutrition customers. A portion of the Company’s fish oil is also partially refined and transferred at cost to the human nutrition segment where it is further refined and concentrated for sale to the human nutrition market. The human nutrition segment is comprised of assets used to produce, procure, market and sell product to human nutrition markets.
	The tables below present information about reported segments for three months ended March 31, 2015 and 2014 (in thousands). It should be noted that all cash and cash equivalent balances have been included in the identifiable assets of the unallocated segment.
	2015	Animal			Human			Unallocated			Total
		Nutrition			Nutrition
	Revenue (1)	$	36,829		$	34,794		$	—		$	71,623
	Cost of sales		26,283			30,545			—			56,828
	Gross profit		10,546			4,249			—			14,795
	Selling, general and administrative expenses (including research and development)		557			5,029			4,604			10,190
	Loss related to plant closure		638			—			—			638
	Other (gains) and losses		307			—			—			307
	Operating income	$	9,044		$	(780	)	$	(4,604	)	$	3,660
	Depreciation and amortization	$	4,273		$	1,499		$	106		$	5,878
	Identifiable assets	$	211,055		$	171,559		$	899		$	383,513
	Capital expenditures	$	9,113		$	951		$	496		$	10,560
	(1) Excludes revenue from internal customers of $0.4 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
	2014	Animal			Human			Unallocated			Total
		Nutrition			Nutrition
	Revenue (2)	$	55,270		$	8,230		$	—		$	63,500
	Cost of sales		36,167			6,840			—			43,007
	Gross profit		19,103			1,390			—			20,493
	Selling, general and administrative expenses (including research and development)		553			1,921			4,103			6,577
	Loss related to plant closure		1,323			—			—			1,323
	Other (gains) and losses		56			191			—			247
	Operating income	$	17,171		$	(722	)	$	(4,103	)	$	12,346
	Depreciation and amortization	$	4,368		$	701		$	148		$	5,217
	Identifiable assets	$	222,761		$	71,814		$	42,256		$	336,831
	Capital expenditures	$	4,597		$	8,209		$	9		$	12,815
	(2) Excludes revenue from internal customers of $0.7 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
	A reconciliation of total segment operating income to total earnings from operations before income taxes is as follows (in thousands):
		Three Months Ended March 31,
		2015			2014
	Operating income for reportable segments	$	3,660		$	12,346
	Interest income		4			8
	Interest expense		(362	)		(247	)
	Loss on foreign currency		(545	)		—
	Other expense, net		(110	)		(56	)
	Income before income taxes	$	2,647		$	12,051

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation
	These interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, the instructions to Quarterly Report on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, certain information and footnote disclosures normally provided have been omitted. The interim financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2014. The year end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.
	In the opinion of management the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the Company’s consolidated financial position as of March 31, 2015, and the results of its operations for the three month periods ended March 31, 2015 and 2014 and its cash flows for the three month periods ended March 31, 2015 and 2014. Quarterly operating results are not necessarily indicative of the results that may be expected for the year ending December 31, 2015.
Consolidation, Policy [Policy Text Block]	Consolidation
	The consolidated financial statements include the accounts of Omega Protein Corporation and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]	Financial Statement Preparation
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Company’s financial statements and the accompanying notes and the reported amounts of revenues and expenses during the reporting period. Actual amounts, when available, could differ from those estimates and those differences could have a material effect on the financial statements.
	As of December 31, 2014, the Company revised the unaudited consolidated balance sheet to correct for the classification of $0.4 million of accounts payable to other long-term liabilities.  This revision was not considered to be material, individually or in the aggregate, to previously issued financial statements. The revisions had no effect on the results of operations (net or comprehensive income) or financial condition (stockholders’ equity).
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition
	The Company derives revenue principally from the sales of a variety of protein and oil products derived from menhaden. In addition and as a result of its acquisitions of Cyvex, InCon, WSP and Bioriginal the Company’s revenues include sales of dietary supplement and food ingredients and products. The Company recognizes revenue for the sale of its products when price is established, collectability is reasonably assured and risk and rewards of ownership of its products and title are transferred to the customer.
Shipping and Handling Cost, Policy [Policy Text Block]	Shipping and Handling
	Amounts billed to customers associated with shipping and handling are included in revenues and the related costs are included in cost of sales.
Inventory, Policy [Policy Text Block]	Inventories
	During the off-seasons, in connection with the upcoming fishing seasons, Omega Protein incurs costs (e.g., plant and vessel related labor, utilities, rent, repairs, and depreciation) that are directly related to Omega Protein’s infrastructure. These costs accumulate in inventory and are applied as elements of the cost of production of Omega Protein’s products throughout the fishing season ratably based on Omega Protein’s monthly units of production and the expected total units of production for the season.
	Any costs incurred during abnormal downtime related to activity at Omega Protein’s plants are charged to expense as incurred.
Derivatives, Policy [Policy Text Block]	Energy Swap Agreements
	The Company does not enter into financial instruments for trading or speculative purposes. Omega Protein entered into energy swap agreements to manage portions of its cash flow exposure related to the volatility of natural gas, diesel and fuel oil energy prices for its fish meal and fish oil production operations. The swaps effectively fix pricing for the quantities listed below during the consumption periods. The fair values of outstanding derivative instruments are summarized as follows:
	Energy Swap		Consumption Period				Quantity				Price Per Unit				Energy Swap Asset/(Liability) as of				Deferred Tax Asset/(Liability) as of
															31-Mar-15				31-Mar-15
															(in thousands)
	Diesel - NYMEX Heating Oil Swap		May - November, 2015				3,038,978 Gallons				$	2.53			$	(2,350	)		$	822
	Natural Gas - NYMEX Natural Gas Swap		April – October, 2015				187,575 MMBTUs				$	3.67				(175	)			61
	Propane – Natural Gas Liquids Swap		June - November, 2015				1,024,800 Gallons				$	0.86				(336	)			118
	Diesel - NYMEX Heating Oil Swap		May - November, 2016				2,050,679 Gallons				$	2.3				(833	)			292
	Natural Gas - NYMEX Natural Gas Swap		April – October, 2016				125,000 MMBTUs				$	3.35				(37	)			13
	Propane – Natural Gas Liquids Swap		June - November, 2016				1,355,000 Gallons				$	0.58				(47	)			16
															$	(3,778	)		$	1,322
	Energy Swap		Consumption Period				Quantity				Price Per Unit				Energy Swap Asset/(Liability) as of				Deferred Tax Asset/(Liability) as of
															31-Dec-14				31-Dec-14
															(in thousands)
	Diesel - NYMEX Heating Oil Swap		May - November, 2015				2,333,848 Gallons				$	2.75			$	(2,097	)		$	734
	Natural Gas - NYMEX Natural Gas Swap		April – October, 2015				114,000 MMBTUs				$	4.09				(125	)			44
	Propane – Natural Gas Liquids Swap		June - November, 2015				1,024,800 Gallons				$	0.86				(346	)			121
	Diesel - NYMEX Heating Oil Swap		May - November, 2016				1,333,464 Gallons				$	2.5				(679	)			238
	Propane – Natural Gas Liquids Swap		June - November, 2016				341,600 Gallons				$	0.67				(41	)			14
															$	(3,288	)		$	1,151
	As of March 31, 2015, Omega Protein has recorded a long-term liability of $0.9 million, net of the current portion included in other current liabilities of $2.9 million, to recognize the fair value of energy swap derivatives, and has also recorded a deferred tax asset of $1.3 million associated therewith. As of December 31, 2014, Omega Protein has recorded a long-term liability of $0.7 million net of the current portion included in other current liabilities of $2.6 million to recognize the fair value of energy swap derivatives, and has also recorded a deferred tax asset of $1.2 million associated therewith. The effective portion of the change in fair value from inception to March 31, 2015 is recorded in “accumulated other comprehensive loss” in the Company’s unaudited condensed consolidated financial statements. The following table illustrates the changes recorded, net of tax, in accumulated other comprehensive loss resulting from the energy swap agreements.
			(in thousands)
			2015				2014
	Balance at January 1,		$	(2,137	)		$	179
	Net change associated with current period swap transactions, net of tax,			(64	)			(18	)
	Balance at March 31,		$	(2,201	)		$	161
	The $2.2 million reported in accumulated other comprehensive loss as of March 31, 2015 will be reclassified to the unallocated inventory cost pool in the period when the energy consumption takes place. The amount to be reclassified, net of taxes, during the next 12 months is expected to be approximately $1.7 million.
	The aggregate fair value of derivative instruments in gross liability positions as of March 31, 2015 and December 31, 2014 was $3.8 million and $3.3 million, respectively. These amounts represent the maximum exposure to loss at the reporting date as a result of all of the counterparties failing to perform as contracted.
	As of March 31, 2015 (in thousands)		Gross Amounts of Recognized Assets (Liabilities)				Gross				Net Amounts of Assets (Liabilities) Presented in the Balance Sheet
							Amounts of
							Assets
							(Liabilities)
							Offset
	Energy swap derivatives – liability position		$	(3,811	)		$	33			$	(3,778	)
	As of December 31, 2014 (in thousands)		Gross Amounts of Recognized Assets (Liabilities)				Gross				Net Amounts of Assets (Liabilities) Presented in the Balance Sheet
							Amounts of
							Assets
							(Liabilities)
							Offset
	Energy swap derivatives – liability position		$	(3,288	)		$	-			$	(3,288	)
	If, at any time, the swaps are determined to be ineffective due to changes in the Company’s energy usage or underlying hedge agreements or assumptions, the fair value of the portion of the energy swaps determined to be ineffective will be recognized as a gain or loss in cost of sales for the applicable period. For the three months ended March 31, 2015 and 2014, the Company recognized a charge of $0.4 million and $0, respectively, to cost of sales resulting from transactions associated with the ineffectiveness of diesel energy swaps. The fair value of all outstanding derivatives is determined using a model with inputs that are observable in the market or can be derived from or corroborated by observable data (level 2).
Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]	Plant Closure
	Property, plant and equipment impairments related to the closure of Cameron, Louisiana plant are made in accordance with the impairment of long-lived assets policy. Employee severance related charges have been recognized to the extent that the amount is probable, measurable and no-future service is expected or for those still employed, recognized pro-rata over the remaining service period. Ongoing clean-up and dismantlement costs will be recognized as incurred unless obligated and measureable by a contractual commitment. See Note 3 – Plant Closure for additional information related to the charges incurred.
Goodwill and Intangible Assets, Policy [Policy Text Block]	Acquisitions, Goodwill and Other Intangible Assets
	All of the Company’s goodwill and other intangible assets are the result of acquisitions in the human nutrition segment. This segment is comprised of three reporting units, 1) InCon and Cyvex, 2) WSP and 3) Bioriginal. The Company has recorded goodwill and certain other identifiable intangible assets that are more fully explained in Note 2 – Acquisition of Bioriginal Food & Science Corp. and Note 9 – Goodwill and Other Intangible Assets.
Comprehensive Income, Policy [Policy Text Block]	Accumulated Other Comprehensive Loss
	The components of accumulated other comprehensive (loss) gain, net of tax, included in stockholders’ equity are as follows:
	Changes in Accumulated Other Comprehensive Loss by Component
	For the Three Months Ended March 31, 2015 (in thousands)
			Gains and Losses					Defined Benefit					Foreign currency				Total
			On Cash Flow					Pension Items					Translation
			Hedges										adjustment
	Balance as of December 31, 2014		$	(2,137	)			$	(7,804	)			$	(915	)		$	(10,856	)
	Other comprehensive loss before reclassifications			(64	)				—					(1,645	)			(1,709	)
	Amounts reclassified from accumulated other comprehensive loss			—		(a)			195		(b)			—				195
	Net current-period other comprehensive income			(64	)				195					(1,645	)			(1,514	)
	Balance as of March 31, 2015		$	(2,201	)			$	(7,609	)			$	(2,560	)		$	(12,370	)
			Gains and Losses					Defined Benefit					Total
			On Cash Flow					Pension Items
			Hedges
	Balance as of December 31, 2013		$	179				$	(6,387	)			$	(6,208	)
	Other comprehensive loss before reclassifications			(18	)				—					(18	)
	Amounts reclassified from accumulated other comprehensive loss			—		(a)			149		(b)			149
	Net current-period other comprehensive income			(18	)				149					131
	Balance as of March 31, 2014		$	161				$	(6,238	)			$	(6,077	)
		(b)	This accumulated other comprehensive income component is included in the computation of net periodic pension costs as amortization of actuarial loss which are explained in more detail in Note 15 to the consolidated financial statements in Item 8 of the Company’s Form 10-K for the fiscal year ended December 31, 2014.
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Standards
	In April 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2015-03, Interest- Imputation of Interest (Subtopic 835-30).  The amendments require that debt issuance costs related to recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debit issuance costs are not affected by the amendments in this update. The new standard is effective in annual periods beginning after December 15, 2015 and interim periods within those annual periods. Early adoption is permitted. The Company’s adoption of FASB ASU No. 2015-03 is not expected to have a material impact on the Company’s consolidated results of operations, financial position and related disclosures.
	In February 2015, the FASB issued ASU 2015-02, Consolidation (Topic 810).  The amendments (1) modify the evaluation of whether limited partnerships and similar legal entities are variable interest entities (VIEs) or voting interest entities, (2) eliminate the presumption that a general partner should consolidate a limited partnership, (3) affect the consolidation analysis of reporting entities that are involved with VIEs, particularly those that have fee arrangements and related party relationships (4) provide a scope exception from consolidation guidance for reporting entities with interest in legal entities that are required to comply with or operate in accordance with requirements that are similar to those in Rule 2a-7 of the Investment Company Act of 1940 for registered money market funds. The new standard is effective in annual periods beginning after December 15, 2015 and interim periods within those annual periods. Early adoption is permitted. The Company’s adoption of FASB ASU No. 2015-02 is not expected to have an impact on the Company’s consolidated results of operations, financial position and related disclosures.
	In January 2015, the FASB issued ASU 2015-01, Income Statement- Extraordinary and Unusual Items (Subtopic 225-20).  The update eliminates from GAAP the concept of extraordinary items. Eliminating the concept of extraordinary items will save time and reduce costs for preparers because they will not have to assess whether a particular event or transaction event is extraordinary. This alleviates uncertainty for preparers, auditors, and regulators because auditors and regulators no longer will need to evaluate whether a preparer treated an unusual and/or infrequent item appropriately. The new standard is effective in annual periods beginning after December 15, 2015 and interim periods within those annual periods. Early adoption is permitted. The Company’s adoption of FASB ASU No. 2015-01 is not expected to have an impact on the Company’s consolidated results of operations, financial position and related disclosures.
	In November 2014, the FASB issued ASU 2014-16, Derivatives and Hedging: Determining whether the Host Contract in a Hybrid Financial Statement Issued in the Form of a Share is More Akin to Debt or Equity.  This ASU amended the Derivatives and Hedging Accounting Standards Codification to eliminate the use of different methods in practice and thereby reduce existing diversity under GAAP in the accounting for hybrid financial instruments used in the form of a share. The new standard is effective in annual periods beginning on or after December 15, 2015 with early adoption permitted. The Company’s adoption of FASB ASU No. 2014-16 is not expected to have an impact on the Company’s consolidated results of operations, financial position and related disclosures.
	In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements- Going Concern (Subtopic 205-40). The amendments require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in the U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The guidance is effective for annual periods ending after December 15, 2016 and for annual periods thereafter. Early adoption is permitted.  The Company does not expect this ASU to have a material impact on the Company’s consolidated results of operations, financial position and related disclosures.
	In June 2014, the FASB issued ASU No. 2014-12, Compensation — Stock Compensation (Topic 718), Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period.  A performance target in a share-based payment that affects vesting and that could be achieved after the requisite service period should be accounted for as a performance condition under Accounting Standards Codification (ASC) 718, Compensation — Stock Compensation. As a result, the target is not reflected in the estimation of the award's grant date fair value. Compensation cost would be recognized over the required service period, if it is probable that the performance condition will be achieved.  The guidance is effective for annual periods beginning after December 15, 2015 and interim periods within those annual periods. Early adoption is permitted.  The Company does not expect this ASU to have a material impact on the Company’s consolidated results of operations, financial position and related disclosures.
	In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers.  This ASU amends the existing accounting standards for revenue recognition and is based on the principle that revenue should be recognized to depict the transfer of goods or services to a customer at an amount that reflects the consideration a company expects to receive in exchange for those goods or services.  The guidance is effective for annual periods beginning after December 15, 2017 and interim periods within those annual periods. The Company is currently evaluating the potential impact of these changes on the consolidated results of operations, financial position and related disclosures.
	In April 2014, the FASB issued ASU No. 2014-08, Presentation of Financial Statements and Property, Plant and Equipment: Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. This ASU changes the criteria for determining which disposals can be presented as discontinued operations and modifies related disclosure requirements. Under the new guidance, a discontinued operation is defined as a disposal of a component or group of components that is disposed of or is classified as held for sale and represents a strategic shift that has or will have a major effect on an entity's operations and financial results. The new standard is effective in annual periods beginning on or after December 15, 2014 with early adoption permitted. The guidance applies prospectively to new disposals and new classifications of disposal groups as held for sale after the effective date. The Company’s adoption of FASB ASU No. 2014-08 effective January 1, 2015 did not have an impact on the Company’s consolidated results of operations, financial position and related disclosures.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign Currency Translations
	All amounts are expressed in U.S. dollars unless otherwise indicated. The U.S. dollar is the functional currency of Bioriginal’s Canadian-based subsidiaries (“Bioriginal Canada”). Monetary assets and liabilities denominated in foreign currencies are translated into U.S. dollars at exchange rates in effect at the balance sheet date. Non-monetary items are translated at rates of exchange in effect when the assets were acquired or obligations incurred. Revenue and expenses are translated at average rates in effect in the period of the transaction. Foreign exchange gains and losses are included in the unaudited condensed consolidated statement of comprehensive income.
	The Euro is the functional currency of Bioriginal’s Netherlands-based subsidiaries (“Bioriginal Europe”). The operations of these subsidiaries are considered self-sustaining and their financial statements are translated into U.S. dollars using the current rate method. Under this method, all assets and liabilities are translated to U.S. dollars at exchange rates in effect at the balance sheet date and all revenue and expenses are translated at rates in effect at the time of the transactions. Exchange gains and losses arising from this translation, representing the net unrealized foreign currency translation gain (loss) on the Company's net investment in its self-sustaining subsidiaries, are recorded in the accumulated other comprehensive income (loss) component of shareholders' equity. Adjustments to the accumulated other comprehensive income (loss) account are not recorded in the unaudited condensed consolidated statement of comprehensive income until realized through a reduction in the Company's net investment in such operations.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation
	Stock Options
	The Company has issued non-qualified stock options under its incentive plans. The options generally vested in equal installments over three years and expire in ten years. As of and for the quarters ended March 31, 2015 and 2014, all stock options were vested and no stock-based compensation costs related to stock options was incurred.
	Restricted Stock
	The Company has issued shares of restricted stock under the 2006 Incentive Plan. Shares of restricted stock have generally vested on the third anniversary of the grant date or in equal installments over three years except for shares of restricted stock granted to non-employee directors which vest six months after the grant date. Non-vested shares are generally forfeited upon the termination of employment or service as a director. Holders of shares of restricted stock are entitled to all rights of a stockholder of the Company, including the right to vote the shares and receive any dividends or other distributions. The non-vested shares are considered participating securities and the Company has calculated earnings per share using the two-class method. See Note 12 – Reconciliation of Basic and Diluted Per Share Data.
	During the three month periods ended March 31, 2015 and 2014, the Company issued 82,072 and 92,545 shares of restricted stock, respectively, under the 2006 Incentive Plan to employees and non-employee directors. The Company’s compensation expense related to restricted stock was approximately $0.5 million and $0.3 million ($0.4 million and $0.2 million after tax) for the three months ended March 31, 2015 and 2014, respectively, which is primarily reflected in selling, general and administrative expenses in the unaudited condensed consolidated statement of comprehensive income. As of March 31, 2015, there was approximately $4.3 million ($2.8 million after tax) of unrecognized compensation expense related to non-vested restricted stock that is expected to be recognized over a weighted-average period of 1.6 years, of which $1.5 million ($0.9 million after-tax) of compensation expense is expected to be recognized during the remainder of fiscal year 2015.
	Performance Units
	On February 6, 2014, the Company adopted the 2014 Cash Incentive Performance Unit Plan and on February 26, 2015, the Company adopted the 2015 Cash Incentive Performance Unit Plan. The value of the units under the plans will be determined by reference to the performance of the Company’s common stock during the relevant performance period compared to the performance of the Russell 2000 Index member companies (the “Peer Group”) during that same period. One third of the Performance Units granted will be earned at the end of each calendar year of the performance period and will be valued for the calendar year based on the Total Shareholder Return (“TSR”) of the Company compared to the TSR of the Peer Group. The performance units contain a service provision of approximately 3 years and are liability-classified awards included in other long-term liabilities which are adjusted to fair value on a quarterly basis.
	The Company’s compensation expense related to performance units was approximately $0.3 million and $0.1 million ($0.2 million and $0.1 million after tax) for the three months ended March 31, 2015 and 2014, respectively, which is primarily reflected in selling, general and administrative expenses in the unaudited condensed consolidated statement of comprehensive income. As of March 31, 2015, there was approximately $2.7 million ($1.7 million after tax) of unrecognized compensation expense related to performance units that is expected to be recognized over a weighted-average period of 2.5 years, of which $0.8 million ($0.5 million after-tax) of compensation expense is expected to be recognized during the remainder of fiscal year 2015.

Note_1_Significant_Accounting_1

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Tables)	3 Months Ended
	Mar. 31, 2015
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Tables) [Line Items]
Schedule of Changes in Accumulated Other Comprehensive Loss, Net of Tax [Table Text Block]		(in thousands)
		2015				2014
	Balance at January 1,	$	(2,137	)		$	179
	Net change associated with current period swap transactions, net of tax,		(64	)			(18	)
	Balance at March 31,	$	(2,201	)		$	161
Offsetting Assets And Liabilities [Table Text Block]	As of March 31, 2015 (in thousands)	Gross Amounts of Recognized Assets (Liabilities)				Gross				Net Amounts of Assets (Liabilities) Presented in the Balance Sheet
						Amounts of
						Assets
						(Liabilities)
						Offset
	Energy swap derivatives – liability position	$	(3,811	)		$	33			$	(3,778	)
	As of December 31, 2014 (in thousands)	Gross Amounts of Recognized Assets (Liabilities)				Gross				Net Amounts of Assets (Liabilities) Presented in the Balance Sheet
						Amounts of
						Assets
						(Liabilities)
						Offset
	Energy swap derivatives – liability position	$	(3,288	)		$	-			$	(3,288	)
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]		Gains and Losses					Defined Benefit					Foreign currency				Total
		On Cash Flow					Pension Items					Translation
		Hedges										adjustment
	Balance as of December 31, 2014	$	(2,137	)			$	(7,804	)			$	(915	)		$	(10,856	)
	Other comprehensive loss before reclassifications		(64	)				—					(1,645	)			(1,709	)
	Amounts reclassified from accumulated other comprehensive loss		—		(a)			195		(b)			—				195
	Net current-period other comprehensive income		(64	)				195					(1,645	)			(1,514	)
	Balance as of March 31, 2015	$	(2,201	)			$	(7,609	)			$	(2,560	)		$	(12,370	)
		Gains and Losses					Defined Benefit					Total
		On Cash Flow					Pension Items
		Hedges
	Balance as of December 31, 2013	$	179				$	(6,387	)			$	(6,208	)
	Other comprehensive loss before reclassifications		(18	)				—					(18	)
	Amounts reclassified from accumulated other comprehensive loss		—		(a)			149		(b)			149
	Net current-period other comprehensive income		(18	)				149					131
	Balance as of March 31, 2014	$	161				$	(6,238	)			$	(6,077	)
Energy Swap [Member]
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Tables) [Line Items]
Schedule of Derivative Instruments [Table Text Block]	Energy Swap	Consumption Period				Quantity				Price Per Unit				Energy Swap Asset/(Liability) as of				Deferred Tax Asset/(Liability) as of
														31-Mar-15				31-Mar-15
														(in thousands)
	Diesel - NYMEX Heating Oil Swap	May - November, 2015				3,038,978 Gallons				$	2.53			$	(2,350	)		$	822
	Natural Gas - NYMEX Natural Gas Swap	April – October, 2015				187,575 MMBTUs				$	3.67				(175	)			61
	Propane – Natural Gas Liquids Swap	June - November, 2015				1,024,800 Gallons				$	0.86				(336	)			118
	Diesel - NYMEX Heating Oil Swap	May - November, 2016				2,050,679 Gallons				$	2.3				(833	)			292
	Natural Gas - NYMEX Natural Gas Swap	April – October, 2016				125,000 MMBTUs				$	3.35				(37	)			13
	Propane – Natural Gas Liquids Swap	June - November, 2016				1,355,000 Gallons				$	0.58				(47	)			16
														$	(3,778	)		$	1,322
	Energy Swap	Consumption Period				Quantity				Price Per Unit				Energy Swap Asset/(Liability) as of				Deferred Tax Asset/(Liability) as of
														31-Dec-14				31-Dec-14
														(in thousands)
	Diesel - NYMEX Heating Oil Swap	May - November, 2015				2,333,848 Gallons				$	2.75			$	(2,097	)		$	734
	Natural Gas - NYMEX Natural Gas Swap	April – October, 2015				114,000 MMBTUs				$	4.09				(125	)			44
	Propane – Natural Gas Liquids Swap	June - November, 2015				1,024,800 Gallons				$	0.86				(346	)			121
	Diesel - NYMEX Heating Oil Swap	May - November, 2016				1,333,464 Gallons				$	2.5				(679	)			238
	Propane – Natural Gas Liquids Swap	June - November, 2016				341,600 Gallons				$	0.67				(41	)			14
														$	(3,288	)		$	1,151

Note_2_Acquisition_of_Biorigin1

Note 2 - Acquisition of Bioriginal Food & Science Corp. (Tables) (Bioriginal [Member])	3 Months Ended
	Mar. 31, 2015
Bioriginal [Member]
Note 2 - Acquisition of Bioriginal Food & Science Corp. (Tables) [Line Items]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	Cash	$	93
	Accounts receivable		15,072
	Inventories		20,309
	Other current assets, net including prepaid expenses		1,820
	Property, plant, and equipment		3,026
	Identifiable intangible assets (a)		16,987
	Liabilities assumed		(38,288	)
	Total identifiable net assets		19,019
	Goodwill		27,462
	Total consideration	$	46,481
Business Acquisition, Pro Forma Information [Table Text Block]		Revenue			Net income
		(in thousands)
	2014 supplemental pro forma from January 1, 2014 – March 31, 2014	$	89,409		$	8,890

Note_3_Plant_Closure_Tables

Note 3 - Plant Closure (Tables)	3 Months Ended
	Mar. 31, 2015
Disposal Groups Plant Closure Disclsoure [Abstract]
Schedule of Disposal Group, Plant Closure Disposal [Table Text Block]		Three Months Ended		December 2013 to March 31, 2015
		31-Mar-15
		(in thousands)
	Impairment of property, plant and equipment	$	—	$	7,922
	Write-off material and supplies inventory		—		150
	Employee severance costs		—		732
	Estimated decommissioning costs		—		250
	Other ongoing closure costs not attributable to future production		638		5,238
	Total loss related to plant closure	$	638	$	14,292

Note_4_Receivables_Net_Tables

Note 4 - Receivables, Net (Tables)	3 Months Ended
	Mar. 31, 2015
Receivables [Abstract]
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]		March 31,			December 31,
		2015			2014
		(in thousands)
	Trade	$	35,742		$	29,534
	Insurance		1,276			1,711
	Income tax		5,205			5,442
	Other		134			370
	Total accounts receivable		42,357			37,057
	Less allowance for doubtful accounts		(403	)		(436	)
	Receivables, net	$	41,954		$	36,621

Note_5_Inventory_Tables

Note 5 - Inventory (Tables)	3 Months Ended
	Mar. 31, 2015
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]		March 31,		December 31,		March 31,
		2015		2014		2014
		(in thousands)
	Fish meal	$	9,343	$	28,400	$	14,988
	Fish oil		15,155		19,300		24,194
	Fish solubles		301		683		1,763
	Nutraceutical products		5,212		4,635		4,299
	Bioriginal products		24,708		26,219		—
	Dairy protein products		2,955		2,783		1,442
	Unallocated inventory cost pool (including off-season costs)		26,707		6,854		25,900
	Other materials and supplies		9,170		8,639		8,829
	Total inventory	$	93,551	$	97,513	$	81,415

Note_6_Prepaid_Expenses_and_Ot1

Note 6 - Prepaid Expenses and Other Current Assets (Tables)	3 Months Ended
	Mar. 31, 2015
Disclosure Text Block Supplement [Abstract]
Schedule of Other Current Assets [Table Text Block]		March 31,		December 31,
		2015		2014
		(in thousands)
	Prepaid insurance	$	1,348	$	2,322
	Product deposits		818		998
	Design expenses		353		331
	Selling expenses		79		156
	Fair value of derivative instruments - energy swaps, current portion		15		—
	Leases		189		168
	Other prepaids and expenses		1,281		961
	Total prepaid expenses and other current assets	$	4,083	$	4,936

Note_7_Other_Assets_Tables

Note 7 - Other Assets (Tables)	3 Months Ended
	Mar. 31, 2015
Disclosure Text Block Supplement [Abstract]
Schedule of Other Assets [Table Text Block]		March 31,		December 31,
		2015		2014
		(in thousands)
	Fish nets, net of accumulated amortization of $3,012 and $2,694	$	881	$	1,195
	Insurance receivable		710		498
	Title XI debt issuance costs		238		246
	Other debt issuance costs		241		264
	Deposits and other		106		106
	Total other assets, net	$	2,176	$	2,309

Note_8_Property_Plant_and_Equi1

Note 8 - Property, Plant, and Equipment (Tables)	3 Months Ended
	Mar. 31, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]		March 31,			December 31,
		2015			2014
		(in thousands)
	Land	$	9,356		$	9,326
	Plant assets		189,043			188,498
	Fishing vessels		110,397			111,379
	Furniture and fixtures		7,822			7,792
	Construction in progress		26,070			15,893
	Total property and equipment		342,688			332,888
	Less accumulated depreciation and impairment		(167,109	)		(162,956	)
	Property, plant and equipment, net	$	175,579		$	169,932

Note_9_Goodwill_and_Other_Inta1

Note 9 - Goodwill and Other Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill [Table Text Block]		Bioriginal			WSP			Cyvex and		Total
								InCon
	1-Jan-15	$	27,045			11,614			3,842	$	42,501
	Foreign currency translation adjustment		(556	)		—			—		(556	)
	31-Mar-15	$	26,489			11,614			3,842	$	41,945
Schedule of Intangible Assets other than Goodwill [Table Text Block]		March 31,			December 31,			Weighted
		2015			2014			Average
								Life (years)
	Carrying value of intangible assets subject to amortization:
	Customer relationships and non-competes	$	19,625		$	19,625
	Less accumulated amortization		(2,837	)		(2,344	)		10
	Total intangible assets subject to amortization, net	$	16,788		$	17,281
	Foreign currency translation adjustment		(431	)		(191	)
	Total intangible assets subject to foreign current translation adjustment, net	$	16,357		$	17,090
	Indefinite life intangible assets – trade names/secrets and other		5,840			5,912
	Total intangible assets	$	22,197		$	23,002
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Remainder of 2015	$	1,478
	2016		1,971
	2017		1,971
	2018		1,971
	Thereafter		9,397
	Total estimated future amortization expense	$	16,788

Note_10_Notes_Payable_and_Long1

Note 10 - Notes Payable and Long-term Debt (Tables)	3 Months Ended
	Mar. 31, 2015
Disclosure Text Block [Abstract]
Schedule of Debt [Table Text Block]		March 31,			December 31,
		2015			2014
		(in thousands)
	U.S. government guaranteed obligations (Title XI loans) collateralized by a first lien on certain vessels and certain plant assets:
	Amounts due in installments through 2025, interest from 5.7% to 7.0%	$	20,478		$	21,111
	Amounts due on Loan Agreement in March 2017, interest at LIBOR plus an applicable rate (1.90% and 1.84% at March 31, 2015 and December 31, 2014, respectively)		3,500			2,000
	ING Commercial Finance B.V., interest at EURIBOR plus an applicable rate (1.70% and 1.76% at March 31, 2015 and December 31, 2014, respectively)		2,161			2,367
	HSBC credit facility, matures March 2019, interest at HSBC prime rate plus an applicable rate (4.5% at March 31, 2015 and December 31, 2014)		13,536			9,749
	Total debt		39,675			35,227
	Less current maturities		(18,379	)		(14,741	)
	Long-term debt	$	21,296		$	20,486

Note_11_Accrued_Liabilities_Ta

Note 11 - Accrued Liabilities (Tables)	3 Months Ended
	Mar. 31, 2015
Disclosure Text Block Supplement [Abstract]
Schedule of Accrued Liabilities [Table Text Block]		March 31,		December 31,
		2015		2014
		(in thousands)
	Insurance	$	6,007	$	5,998
	Reserve for plant closure costs		327		456
	Salary and benefits		4,552		7,273
	Trade creditors		7,290		5,045
	Taxes, other than income tax		605		222
	Income tax		701		—
	Energy swap liability, current portion		2,876		2,568
	Deferred revenue		538		1,400
	Accrued interest		244		246
	Other		—		8
	Total accrued liabilities	$	23,140	$	23,216

Note_13_Reconciliation_of_Basi1

Note 13 - Reconciliation of Basic and Diluted Per Share Data (Tables)	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended March 31:	2015				2014
	Allocation of earnings:
	Net income	$	1,669			$	7,971
	Income allocated to participating securities		(44	)			(192	)
	Income allocated to common shares outstanding	$	1,625			$	7,779
	Weighted average common shares outstanding		21,006				20,355
	Basic earnings per share				0.08				0.38
	Stock options assumed exercised		460				659
	Weighted average diluted common shares and potential common share equivalents outstanding		21,466				21,014
	Diluted earnings per share				0.08				0.37
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Three Months Ended March 31,
	2015	2014
	125	130

Note_14_Components_of_Net_Peri1

Note 14 - Components of Net Periodic Benefit Cost (Tables)	3 Months Ended
	Mar. 31, 2015
Compensation and Retirement Disclosure [Abstract]
Schedule of Net Benefit Costs [Table Text Block]		Three Months Ended
		March 31,
		2015			2014
		(in thousands)
	Service cost	$	—		$	—
	Interest cost		230			274
	Expected return on plan assets		(276	)		(298	)
	Amortization of prior service costs		—			—
	Amortization of net loss		300			229
	Net periodic pension cost	$	254		$	205

Note_15_Industry_Segments_Tabl

Note 15 - Industry Segments (Tables)	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	2015	Animal			Human			Unallocated			Total
		Nutrition			Nutrition
	Revenue (1)	$	36,829		$	34,794		$	—		$	71,623
	Cost of sales		26,283			30,545			—			56,828
	Gross profit		10,546			4,249			—			14,795
	Selling, general and administrative expenses (including research and development)		557			5,029			4,604			10,190
	Loss related to plant closure		638			—			—			638
	Other (gains) and losses		307			—			—			307
	Operating income	$	9,044		$	(780	)	$	(4,604	)	$	3,660
	Depreciation and amortization	$	4,273		$	1,499		$	106		$	5,878
	Identifiable assets	$	211,055		$	171,559		$	899		$	383,513
	Capital expenditures	$	9,113		$	951		$	496		$	10,560
	2014	Animal			Human			Unallocated			Total
		Nutrition			Nutrition
	Revenue (2)	$	55,270		$	8,230		$	—		$	63,500
	Cost of sales		36,167			6,840			—			43,007
	Gross profit		19,103			1,390			—			20,493
	Selling, general and administrative expenses (including research and development)		553			1,921			4,103			6,577
	Loss related to plant closure		1,323			—			—			1,323
	Other (gains) and losses		56			191			—			247
	Operating income	$	17,171		$	(722	)	$	(4,103	)	$	12,346
	Depreciation and amortization	$	4,368		$	701		$	148		$	5,217
	Identifiable assets	$	222,761		$	71,814		$	42,256		$	336,831
	Capital expenditures	$	4,597		$	8,209		$	9		$	12,815
Reconciliation of Operating Income to Total Earnings Before Income Taxes [Table Text Block]		Three Months Ended March 31,
		2015			2014
	Operating income for reportable segments	$	3,660		$	12,346
	Interest income		4			8
	Interest expense		(362	)		(247	)
	Loss on foreign currency		(545	)		—
	Other expense, net		(110	)		(56	)
	Income before income taxes	$	2,647		$	12,051

Note_1_Significant_Accounting_2

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) (USD $)	3 Months Ended		12 Months Ended	9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2013
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) [Line Items]
Number of Operating Segments	2
Derivative Liability, Current	$2,876,000		$2,568,000
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax	-2,201,000	161,000	-2,137,000		179,000
Accumulated Other Comprehensive Income Reclassified to Inventory Cost	1,700,000
Derivative Liability, Fair Value, Gross Liability	3,800,000		3,300,000
Cost of Goods and Services Sold	56,828,000	43,007,000
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares)		92,545
Reclassification from Accounts Payable to Long-term Liabilities [Member]
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) [Line Items]
Prior Period Reclassification Adjustment			400,000
Scenario, Forecast [Member] | Restricted Stock [Member]
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) [Line Items]
Allocated Share-based Compensation Expense				1,500,000
Allocated Share-based Compensation Expense, Net of Tax				900,000
Scenario, Forecast [Member] | Performance Shares [Member]
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) [Line Items]
Allocated Share-based Compensation Expense				800,000
Allocated Share-based Compensation Expense, Net of Tax				500,000
Animal Nutrition [Member]
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) [Line Items]
Number of Subsidiaries	2
Human Nutrition [Member]
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) [Line Items]
Number of Subsidiaries	3
Numer of Product Lines	3
Number of Reporting Units	3
Employee Stock Option [Member]
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	10 years
Allocated Share-based Compensation Expense	0	0
Restricted Stock [Member] | Non-Employee Directors [Member]
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	6 months
Restricted Stock [Member]
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Allocated Share-based Compensation Expense	500,000	300,000
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares)	82,072
Allocated Share-based Compensation Expense, Net of Tax	400,000	200,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	4,300,000
EmployeeServiceShareBasedCompensationNonvested Awards Total Compensation Cost Not Yet Recognized Net	2,800,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	1 year 219 days
Performance Shares [Member]
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Allocated Share-based Compensation Expense	300,000	100,000
Allocated Share-based Compensation Expense, Net of Tax	200,000	100,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	2,700,000
EmployeeServiceShareBasedCompensationNonvested Awards Total Compensation Cost Not Yet Recognized Net	1,700,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	2 years 6 months
Unallocated Inventory and Net Change with Current Period Swap Transaction [Member]
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) [Line Items]
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax	2,200,000
Energy Swap [Member]
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) [Line Items]
Derivative Liability, Noncurrent	900,000		700,000
Derivative Liability, Current	2,900,000		2,600,000
Deferred Tax Assets, Derivative Instruments	1,300,000		1,200,000
Ineffective Portion of Diesel Energy Swaps [Member]
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) [Line Items]
Cost of Goods and Services Sold	$400,000	$0

Note_1_Significant_Accounting_3

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Energy Swap Balances (USD $)	3 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
	gal	gal
NYMEX Heating Oil Swap [Member] | May - November, 2015 [Member]
Derivative [Line Items]
Quantity (in US Gallons)	3,038,978	2,333,848
Price Per Unit (in Dollars per Item)	2.53	2.75
Energy Swap Asset/(Liability)	($2,350)	($2,097)
Deferred Tax Asset/(Liability)	822	734
Price Per Unit, Gas Swap (in Dollars per Item)	2.53	2.75
Energy Swap Asset/(Liability), Gas Swap	-2,350	-2,097
Deferred Tax Asset/(Liability), Gas Swap	822	734
NYMEX Heating Oil Swap [Member] | May - November, 2016 [Member]
Derivative [Line Items]
Quantity (in US Gallons)	2,050,679	1,333,464
Price Per Unit (in Dollars per Item)	2.3	2.5
Energy Swap Asset/(Liability)	-833	-679
Deferred Tax Asset/(Liability)	292	238
Price Per Unit, Gas Swap (in Dollars per Item)	2.3	2.5
Energy Swap Asset/(Liability), Gas Swap	-833	-679
Deferred Tax Asset/(Liability), Gas Swap	292	238
NYMEX Natural Gas Swap [Member] | April - October, 2015 [Member]
Derivative [Line Items]
Price Per Unit (in Dollars per Item)	3.67	4.09
Energy Swap Asset/(Liability)	-175	-125
Deferred Tax Asset/(Liability)	61	44
Quantity, Gas Swap (in Millions of British Thermal Units)	187,575	114,000
Price Per Unit, Gas Swap (in Dollars per Item)	3.67	4.09
Energy Swap Asset/(Liability), Gas Swap	-175	-125
Deferred Tax Asset/(Liability), Gas Swap	61	44
NYMEX Natural Gas Swap [Member] | April - October 2016 [Member]
Derivative [Line Items]
Price Per Unit (in Dollars per Item)	3.35
Energy Swap Asset/(Liability)	-37
Deferred Tax Asset/(Liability)	13
Quantity, Gas Swap (in Millions of British Thermal Units)	125,000
Price Per Unit, Gas Swap (in Dollars per Item)	3.35
Energy Swap Asset/(Liability), Gas Swap	-37
Deferred Tax Asset/(Liability), Gas Swap	13
Natural Gas Liquids Swap [Member] | June - November, 2015 [Member]
Derivative [Line Items]
Quantity (in US Gallons)	1,024,800	1,024,800
Price Per Unit (in Dollars per Item)	0.86	0.86
Energy Swap Asset/(Liability)	-336	-346
Deferred Tax Asset/(Liability)	118	121
Price Per Unit, Gas Swap (in Dollars per Item)	0.86	0.86
Energy Swap Asset/(Liability), Gas Swap	-336	-346
Deferred Tax Asset/(Liability), Gas Swap	118	121
Natural Gas Liquids Swap [Member] | June - November, 2016 [Member]
Derivative [Line Items]
Quantity (in US Gallons)	1,355,000	341,600
Price Per Unit (in Dollars per Item)	0.58	0.67
Energy Swap Asset/(Liability)	-47	-41
Deferred Tax Asset/(Liability)	16	14
Price Per Unit, Gas Swap (in Dollars per Item)	0.58	0.67
Energy Swap Asset/(Liability), Gas Swap	-47	-41
Deferred Tax Asset/(Liability), Gas Swap	16	14
Energy Swap [Member]
Derivative [Line Items]
Energy Swap Asset/(Liability)	-3,778	-3,288
Deferred Tax Asset/(Liability)	1,322	1,151
Energy Swap Asset/(Liability), Gas Swap	-3,778	-3,288
Deferred Tax Asset/(Liability), Gas Swap	$1,322	$1,151

Note_1_Significant_Accounting_4

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Changes Recorded, Net of Tax, in Accumulated Other Comprehensive Loss Resulting From the Energy Swap Agreements (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Changes Recorded, Net of Tax, in Accumulated Other Comprehensive Loss Resulting From the Energy Swap Agreements [Line Items]
Gains and Losses on Cash Flow Hedges	($2,137)	$179
Net change associated with current period swap transactions, net of tax,	-64	-18
Gains and Losses on Cash Flow Hedges	-2,201	161
Swap [Member] | Energy Related Derivative [Member]
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Changes Recorded, Net of Tax, in Accumulated Other Comprehensive Loss Resulting From the Energy Swap Agreements [Line Items]
Net change associated with current period swap transactions, net of tax,	-64	-18
Energy Related Derivative [Member]
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Changes Recorded, Net of Tax, in Accumulated Other Comprehensive Loss Resulting From the Energy Swap Agreements [Line Items]
Gains and Losses on Cash Flow Hedges			-2,137	179
Gains and Losses on Cash Flow Hedges	($2,201)	$161	($2,137)	$179

Note_1_Significant_Accounting_5

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Gross Amounts, Gross Amounts Offset and Net Amounts of Assets Presented in Balance Sheet (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Gross Amounts, Gross Amounts Offset and Net Amounts of Assets Presented in Balance Sheet [Abstract]
Gross Amount of Recognized Assets (Liabilities)	($3,811)	($3,288)
Gross Amounts of Assets (Liabilities) Offset	33
Net Amounts of Assets (Liabilities) Presented in the Balance Sheet	($3,778)	($3,288)

Note_1_Significant_Accounting_6

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Changes in Accumulated Other Comprehensive Loss (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015		Mar. 31, 2014
Changes in Accumulated Other Comprehensive Loss [Abstract]
Gains and Losses on Cash Flow Hedges	($2,137)		$179
Defined Benefit Pension Items	-7,804		-6,387
Foreign Currency Translation Adjustment	-915
Total	-10,856		-6,208
Other comprehensive loss before reclassifications	-64		-18
Other comprehensive loss before reclassifications	-1,645
Other comprehensive loss before reclassifications	-1,709		-18
Amounts reclassified from accumulated other comprehensive loss		[1]		[1]
Amounts reclassified from accumulated other comprehensive loss	195	[2]	149	[2]
Amounts reclassified from accumulated other comprehensive loss	195		149
Net current-period other comprehensive income	-64		-18
Net current-period other comprehensive income	195		149
Net current-period other comprehensive income	-1,645
Net current-period other comprehensive income	-1,514		131
Gains and Losses on Cash Flow Hedges	-2,201		161
Defined Benefit Pension Items	-7,609		-6,238
Foreign Currency Translation Adjustment	-2,560
Total	($12,370)		($6,077)
[1]	This accumulated other comprehensive income component is reclassified to the unallocated inventory cost pool in the period when the energy consumption takes place.
[2]	This accumulated other comprehensive income component is included in the computation of net periodic pension costs as amortization of actuarial loss which are explained in more detail in Note 15 to the consolidated financial statements in Item 8 of the Company's Form 10-K for the fiscal year ended December 31, 2014.

Note_2_Acquisition_of_Biorigin2

Note 2 - Acquisition of Bioriginal Food & Science Corp. (Details) (Bioriginal [Member])	0 Months Ended				3 Months Ended	4 Months Ended
	Sep. 05, 2014	Sep. 05, 2014	Sep. 05, 2014	Sep. 05, 2014	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2014	Sep. 05, 2014
	Aggrgegate Purchase Price [Member]	Estimated Working Capital [Member]	USD ($)	USD ($)	USD ($)	USD ($)	CAD	CAD
	USD ($)	USD ($)
Note 2 - Acquisition of Bioriginal Food & Science Corp. (Details) [Line Items]
Business Combination, Consideration Transferred	$70,500,000			$46,481,000
Payments to Acquire Businesses, Gross		700,000	46,500,000
Business Combination, Consideration Transferred, Liabilities Incurred			21,500,000
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in Shares)			238,377
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned				3,200,000
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High (in Dollars)							7,100,000	7,100,000
Proceeds from Previous Acquisition					100,000
Business Combination, Acquisition Related Costs						$2,800,000

Note_2_Acquisition_of_Biorigin3

Note 2 - Acquisition of Bioriginal Food & Science Corp. (Details) - Fair Value of the Bioriginal Assets and Acquired Liabilities Assumed (USD $)	0 Months Ended
In Thousands, unless otherwise specified	Sep. 05, 2014		Mar. 31, 2015	Dec. 31, 2014
Note 2 - Acquisition of Bioriginal Food & Science Corp. (Details) - Fair Value of the Bioriginal Assets and Acquired Liabilities Assumed [Line Items]
Goodwill			$41,945	$42,501
Bioriginal [Member]
Note 2 - Acquisition of Bioriginal Food & Science Corp. (Details) - Fair Value of the Bioriginal Assets and Acquired Liabilities Assumed [Line Items]
Cash	93
Accounts receivable	15,072
Inventories	20,309
Other current assets, net including prepaid expenses	1,820
Property, plant, and equipment	3,026
Identifiable intangible assets (a)	16,987	[1]
Liabilities assumed	-38,288
Total identifiable net assets	19,019
Goodwill	27,462		26,489	27,045
Total consideration	$46,481
[1]	See Note 9 - Goodwill and Other Intangible Assets for weighted average lives.

Note_2_Acquisition_of_Biorigin4

Note 2 - Acquisition of Bioriginal Food & Science Corp. (Details) - Pro Forma Financial Information (Bioriginal [Member], USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014
Bioriginal [Member]
Note 2 - Acquisition of Bioriginal Food & Science Corp. (Details) - Pro Forma Financial Information [Line Items]
2014 supplemental pro forma from January 1, 2014 – March 31, 2014	$89,409
2014 supplemental pro forma from January 1, 2014 – March 31, 2014	$8,890

Note_3_Plant_Closure_Details_C

Note 3 - Plant Closure (Details) - Charges Incurred in Conjunction with Plant Closure (USD $)	3 Months Ended		16 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015
Note 3 - Plant Closure (Details) - Charges Incurred in Conjunction with Plant Closure [Line Items]
Total loss related to plant closure	$638	$1,323
Cameron, Louisiana Menhaden Processing Plant [Member]
Note 3 - Plant Closure (Details) - Charges Incurred in Conjunction with Plant Closure [Line Items]
Impairment of property, plant and equipment			7,922
Write-off material and supplies inventory			150
Employee severance costs			732
Estimated decommissioning costs			250
Other ongoing closure costs not attributable to future production	638		5,238
Total loss related to plant closure	$638		$14,292

Note_4_Receivables_Net_Details

Note 4 - Receivables, Net (Details) - Receivables (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Receivables [Abstract]
Trade	$35,742	$29,534
Insurance	1,276	1,711
Income tax	5,205	5,442
Other	134	370
Total accounts receivable	42,357	37,057
Less allowance for doubtful accounts	-403	-436
Receivables, net	$41,954	$36,621

Note_5_Inventory_Details_Class

Note 5 - Inventory (Details) - Classes of Inventory (USD $)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014
In Thousands, unless otherwise specified
Inventory [Line Items]
Unallocated inventory cost pool (including off-season costs)	$26,707	$6,854	$25,900
Other materials and supplies	9,170	8,639	8,829
Total inventory	93,551	97,513	81,415
Class, Fish Meal [Member]
Inventory [Line Items]
Inventory Goods	9,343	28,400	14,988
Class, Fish Oil [Member]
Inventory [Line Items]
Inventory Goods	15,155	19,300	24,194
Class, Fish Solubles [Member]
Inventory [Line Items]
Inventory Goods	301	683	1,763
Class, Nutraceutical Products [Member]
Inventory [Line Items]
Inventory Goods	5,212	4,635	4,299
Class, Bioriginal Essential Fatty Acid Products [Member]
Inventory [Line Items]
Inventory Goods	24,708	26,219
Class, Dairy Protein Products [Member]
Inventory [Line Items]
Inventory Goods	$2,955	$2,783	$1,442

Note_6_Prepaid_Expenses_and_Ot2

Note 6 - Prepaid Expenses and Other Current Assets (Details) - Prepaid Expenses and Other Current Assets (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Prepaid Expenses and Other Current Assets [Abstract]
Prepaid insurance	$1,348	$2,322
Product deposits	818	998
Design expenses	353	331
Selling expenses	79	156
Fair value of derivative instruments - energy swaps, current portion	15
Leases	189	168
Other prepaids and expenses	1,281	961
Total prepaid expenses and other current assets	$4,083	$4,936

Note_7_Other_Assets_Details

Note 7 - Other Assets (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Disclosure Text Block Supplement [Abstract]
Amortization	$0.30	$0.30

Note_7_Other_Assets_Details_Ot

Note 7 - Other Assets (Details) - Other Assets (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Note 7 - Other Assets (Details) - Other Assets [Line Items]
Other Asset, Net	$2,176	$2,309
Insurance receivable	710	498
Property, Leased, Fishing Nets [Member]
Note 7 - Other Assets (Details) - Other Assets [Line Items]
Other Asset, Net	881	1,195
Title XI Debt Issuance Costs [Member]
Note 7 - Other Assets (Details) - Other Assets [Line Items]
Other Asset, Net	238	246
Other Debt Issuance Costs [Member]
Note 7 - Other Assets (Details) - Other Assets [Line Items]
Other Asset, Net	241	264
Deposits and Other [Member]
Note 7 - Other Assets (Details) - Other Assets [Line Items]
Other Asset, Net	$106	$106

Note_7_Other_Assets_Details_Ot1

Note 7 - Other Assets (Details) - Other Assets (Parentheticals) (Property, Leased, Fishing Nets [Member], USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Property, Leased, Fishing Nets [Member]
Note 7 - Other Assets (Details) - Other Assets (Parentheticals) [Line Items]
Fish nets, accumulated amortization	$3,012	$2,694

Note_8_Property_Plant_and_Equi2

Note 8 - Property, Plant, and Equipment (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Property, Plant and Equipment [Abstract]
Depreciation	$5.10	$4.70
Interest Costs Capitalized	$0.20	$0.20

Note_8_Property_Plant_and_Equi3

Note 8 - Property, Plant, and Equipment (Details) - Property, Plant, and Equipment (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Property, Plant and Equipment [Line Items]
Property, Plant, and Equipment	$342,688	$332,888
Less accumulated depreciation and impairment	-167,109	-162,956
Property, plant and equipment, net	175,579	169,932
Land [Member]
Property, Plant and Equipment [Line Items]
Property, Plant, and Equipment	9,356	9,326
Equipment, Plant [Member]
Property, Plant and Equipment [Line Items]
Property, Plant, and Equipment	189,043	188,498
Property, Fishing Vessels [Member]
Property, Plant and Equipment [Line Items]
Property, Plant, and Equipment	110,397	111,379
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, Plant, and Equipment	7,822	7,792
Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Property, Plant, and Equipment	$26,070	$15,893

Note_9_Goodwill_and_Other_Inta2

Note 9 - Goodwill and Other Intangible Assets (Details) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Note 9 - Goodwill and Other Intangible Assets (Details) [Line Items]
Indefinite-Lived Intangible Assets (Excluding Goodwill)	$5,840,000		$5,912,000
Amortization of Intangible Assets	500,000	200,000
WSP [Member] | Trade Secrets [Member] | Minimum [Member]
Note 9 - Goodwill and Other Intangible Assets (Details) [Line Items]
Fair Value in Excess of Carrying Value, Percentage			100.00%
WSP [Member] | Maximum [Member] | Goodwill [Member]
Note 9 - Goodwill and Other Intangible Assets (Details) [Line Items]
Fair Value in Excess of Carrying Value, Percentage			1.00%
Trade Secrets [Member] | WSP [Member]
Note 9 - Goodwill and Other Intangible Assets (Details) [Line Items]
Indefinite-Lived Intangible Assets (Excluding Goodwill)			1,100,000
InCon [Member]
Note 9 - Goodwill and Other Intangible Assets (Details) [Line Items]
Goodwill and Intangible Asset Impairment			600,000
Cyvex [Member]
Note 9 - Goodwill and Other Intangible Assets (Details) [Line Items]
Goodwill and Intangible Asset Impairment			4,100,000
Cyvex and Incon [Member]
Note 9 - Goodwill and Other Intangible Assets (Details) [Line Items]
Goodwill and Intangible Asset Impairment			$4,700,000

Note_9_Goodwill_and_Other_Inta3

Note 9 - Goodwill and Other Intangible Assets (Details) - Changes in Carrying Amount of Goodwill Resulting from Company's Acquisitions (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014	Sep. 05, 2014
Goodwill [Line Items]
Goodwill		$42,501
Goodwill	41,945	42,501
Bioriginal [Member]
Goodwill [Line Items]
Goodwill	27,045		27,462
Foreign currency translation adjustment	-556
Goodwill	26,489		27,462
WSP [Member]
Goodwill [Line Items]
Goodwill		11,614
Goodwill	11,614	11,614
Cyvex and Incon [Member]
Goodwill [Line Items]
Goodwill		3,842
Goodwill	$3,842	$3,842

Note_9_Goodwill_and_Other_Inta4

Note 9 - Goodwill and Other Intangible Assets (Details) - Table of Intangible Assets Other than Goodwill (USD $)	3 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Table of Intangible Assets Other than Goodwill [Abstract]
Customer relationships and non-competes	$19,625	$19,625
Less accumulated amortization	-2,837	-2,344
Less accumulated amortization	10 years
Total intangible assets subject to amortization, net	16,788	17,281
Foreign currency translation adjustment	-431	-191
Total intangible assets subject to foreign current translation adjustment, net	16,357	17,090
Indefinite life intangible assets – trade names/secrets and other	5,840	5,912
Total intangible assets	$22,197	$23,002

Note_9_Goodwill_and_Other_Inta5

Note 9 - Goodwill and Other Intangible Assets (Details) - Table of Future Amortization Expense (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Table of Future Amortization Expense [Abstract]
Remainder of 2015	$1,478
2016	1,971
2017	1,971
2018	1,971
Thereafter	9,397
Total estimated future amortization expense	$16,788	$17,281

Note_10_Notes_Payable_and_Long2

Note 10 - Notes Payable and Long-term Debt (Details)

Mar. 31, 2015

Dec. 31, 2014

Jun. 06, 2010

Mar. 31, 2015

Jun. 06, 2010

Mar. 31, 2015

Mar. 31, 2015

Apr. 15, 2014

Mar. 31, 2015

Apr. 15, 2014

Mar. 31, 2015

Apr. 15, 2014

Mar. 31, 2015

Mar. 31, 2015

Jun. 20, 2011

Mar. 31, 2015

Dec. 31, 2014

Sep. 30, 2014

Mar. 21, 2012

USD ($)

USD ($)

ING Bank N.V. [Member]

ING Bank N.V. [Member]

ING Bank N.V. [Member]

ING Commercial Finance B.V. [Member]

ING Commercial Finance B.V. [Member]

HSBC Bank of Canada [Member]

HSBC Bank of Canada [Member]

HSBC Bank of Canada [Member]

HSBC Bank of Canada [Member]

HSBC Bank of Canada [Member]

HSBC Bank of Canada [Member]

Approval Letter [Member]

Approval Letter [Member]

Loan Agreement [Member]

Loan Agreement [Member]

Loan Agreement [Member]

Loan Agreement [Member]

EURIBOR [Member]

Bioriginal [Member]

Bioriginal [Member]

EURIBOR [Member]

Bioriginal [Member]

Prime Rate [Member]

Bioriginal [Member]

Bioriginal [Member]

Bioriginal [Member]

Bioriginal [Member]

Bioriginal [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Bioriginal [Member]

Line of Credit [Member]

Line of Credit [Member]

Bioriginal [Member]

Line of Credit [Member]

Bioriginal [Member]

Line of Credit [Member]

Line of Credit [Member]

Letter of Credit [Member]

Letter of Credit [Member]

USD ($)

Line of Credit [Member]

USD ($)

EUR (€)

Line of Credit [Member]

Line of Credit [Member]

USD ($)

CAD

USD ($)

USD ($)

Note 10 - Notes Payable and Long-term Debt (Details) [Line Items]

Long-term Debt, Fair Value

$41,300,000

$36,900,000

Line of Credit Facility, Maximum Borrowing Capacity

250,000

20,000,000

4,200,000

10,000,000

70,000,000

60,000,000

Long-term Line of Credit

0

2,200,000

13,500,000

20,500,000

3,500,000

3,500,000

Line of Credit Facility, Maximum Borrowing Capacity Increase

10,000,000

Letters of Credit Outstanding, Amount

$3,500,000

$3,500,000

$4,200,000

$3,500,000

Debt Instrument, Basis Spread on Variable Rate

2.97%

1.75%

1.25%

Line of Credit Facility, Interest Rate at Period End

2.98%

1.70%

4.50%

Line of Credit Facility, Secured by Accounts Receivable, Maximum Percentage

85.00%

Line of Credit Facility, Secured by Inventory, Maximum Percentage

60.00%

Note_10_Notes_Payable_and_Long3

Note 10 - Notes Payable and Long-term Debt (Details) - Table of Long-term Debt (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
U.S. government guaranteed obligations (Title XI loans) collateralized by a first lien on certain vessels and certain plant assets:
Long-term debt	$39,675	$35,227
Less current maturities	-18,379	-14,741
Long-term debt	21,296	20,486
Installments Through 2025 [Member]
U.S. government guaranteed obligations (Title XI loans) collateralized by a first lien on certain vessels and certain plant assets:
Long-term debt	20,478	21,111
Loan Agreement [Member]
U.S. government guaranteed obligations (Title XI loans) collateralized by a first lien on certain vessels and certain plant assets:
Long-term debt	3,500	2,000
ING Commercial Finance B.V Credit Facility [Member]
U.S. government guaranteed obligations (Title XI loans) collateralized by a first lien on certain vessels and certain plant assets:
Long-term debt	2,161	2,367
HSBC Credit Facility [Member]
U.S. government guaranteed obligations (Title XI loans) collateralized by a first lien on certain vessels and certain plant assets:
Long-term debt	$13,536	$9,749

Note_10_Notes_Payable_and_Long4

Note 10 - Notes Payable and Long-term Debt (Details) - Table of Long-term Debt (Parentheticals)	Mar. 31, 2015	Dec. 31, 2014
Minimum [Member] | Installments Through 2025 [Member]
Note 10 - Notes Payable and Long-term Debt (Details) - Table of Long-term Debt (Parentheticals) [Line Items]
Interest rate	5.70%	5.70%
Maximum [Member] | Installments Through 2025 [Member]
Note 10 - Notes Payable and Long-term Debt (Details) - Table of Long-term Debt (Parentheticals) [Line Items]
Interest rate	7.00%	7.00%
Loan Agreement [Member]
Note 10 - Notes Payable and Long-term Debt (Details) - Table of Long-term Debt (Parentheticals) [Line Items]
Interest rate	1.90%	1.84%
ING Commercial Finance B.V Credit Facility [Member]
Note 10 - Notes Payable and Long-term Debt (Details) - Table of Long-term Debt (Parentheticals) [Line Items]
Interest rate	1.70%	1.76%
HSBC Credit Facility [Member]
Note 10 - Notes Payable and Long-term Debt (Details) - Table of Long-term Debt (Parentheticals) [Line Items]
Interest rate	4.50%	4.50%

Note_11_Accrued_Liabilities_De

Note 11 - Accrued Liabilities (Details) - Accrued Liabilities (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Accrued Liabilities [Abstract]
Insurance	$6,007	$5,998
Reserve for plant closure costs	327	456
Salary and benefits	4,552	7,273
Trade creditors	7,290	5,045
Taxes, other than income tax	605	222
Income tax	701
Energy swap liability, current portion	2,876	2,568
Deferred revenue	538	1,400
Accrued interest	244	246
Other		8
Total accrued liabilities	$23,140	$23,216

Note_12_Commitments_and_Contin1

Note 12 - Commitments and Contingencies (Details)	Mar. 31, 2015	Dec. 31, 2014	Sep. 05, 2014	Sep. 05, 2014	Dec. 31, 2014	Dec. 31, 2014	Sep. 05, 2014
In Millions, unless otherwise specified	USD ($)	Annual Earnout Payment [Member]	Annual Earnout Payment [Member]	Bioriginal [Member]	Bioriginal [Member]	Bioriginal [Member]	Bioriginal [Member]
		Bioriginal [Member]	Bioriginal [Member]		USD ($)	CAD	CAD
		CAD	CAD
Note 12 - Commitments and Contingencies (Details) [Line Items]
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low			1.2
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High			2.9			7.1	7.1
Business Combination, Contingent Consideration Arrangements, Term of Earn-out Payments				3 years
Business Combination, Contingent Consideration, Liability (in Dollars)	0.7				0.4
Business Combination, Contingent Consideration Arrangements, Threshold Expected to Have Been Achieved During Period		1.2

Note_13_Reconciliation_of_Basi2

Note 13 - Reconciliation of Basic and Diluted Per Share Data (Details) - Reconciliation of Basic and Diluted Per Share Data (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Allocation of earnings:
Net income	$1,669	$7,971
Income allocated to participating securities	-44	-192
Income allocated to common shares outstanding	$1,625	$7,779
Weighted average common shares outstanding	21,006	20,355
Basic earnings per share	$0.08	$0.38
Stock options assumed exercised	460	659
Weighted average diluted common shares and potential common share equivalents outstanding	21,466	21,014
Diluted earnings per share	$0.08	$0.37

Note_13_Reconciliation_of_Basi3

Note 13 - Reconciliation of Basic and Diluted Per Share Data (Details) - Outstanding Shares Excluded from Computation of Diluted Earnings Per Share	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Outstanding Shares Excluded from Computation of Diluted Earnings Per Share [Abstract]
	125	130

Note_14_Components_of_Net_Peri2

Note 14 - Components of Net Periodic Benefit Cost (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Pension Contributions	$0.40	$0.40
Defined Benefit Plan, Expected Contributions in Current Fiscal Year	$0.80

Note_14_Components_of_Net_Peri3

Note 14 - Components of Net Periodic Benefit Cost (Details) - Summary of Components of Net Periodic Benefit Cost (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Summary of Components of Net Periodic Benefit Cost [Abstract]
Interest cost	$230	$274
Expected return on plan assets	-276	-298
Amortization of net loss	300	229
Net periodic pension cost	$254	$205

Note_15_Industry_Segments_Deta

Note 15 - Industry Segments (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015		Mar. 31, 2014
Note 15 - Industry Segments (Details) [Line Items]
Number of Reportable Segments	2
Revenues	$71,623	[1]	$63,500	[2]
Intersegment Eliminations [Member]
Note 15 - Industry Segments (Details) [Line Items]
Revenues	$400		$700
[1]	Excludes revenue from internal customers of $0.4 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment atcost.
[2]	Excludes revenue from internal customers of $0.7 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment atcost.

Note_15_Industry_Segments_Deta1

Note 15 - Industry Segments (Details) - Reported Segments (USD $)	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014		Dec. 31, 2014
Segment Reporting Information [Line Items]
Revenue	$71,623,000	[1]	$63,500,000	[2]
Cost of sales	56,828,000		43,007,000
Gross profit	14,795,000		20,493,000
Selling, general and administrative expenses (including research and development)	10,190,000		6,577,000
Loss (gain) on disposal of assets	638,000		1,323,000
Other (gains) and losses	307,000		247,000
Operating income	3,660,000		12,346,000
Depreciation and amortization	5,878,000		5,217,000
Identifiable assets	383,553,000		336,831,000		380,115,000
Capital expenditures	10,560,000		12,815,000
Animal Nutrition [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue	36,829,000	[1]	55,270,000	[2]
Cost of sales	26,283,000		36,167,000
Gross profit	10,546,000		19,103,000
Selling, general and administrative expenses (including research and development)	557,000		553,000
Loss (gain) on disposal of assets	638,000		1,323,000
Other (gains) and losses	307,000		56,000
Operating income	9,044,000		17,171,000
Depreciation and amortization	4,273,000		4,368,000
Identifiable assets	211,055,000		222,761,000
Capital expenditures	9,113,000		4,597,000
Human Nutrition [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue	34,794,000		8,230,000	[2]
Cost of sales	30,545,000		6,840,000
Gross profit	4,249,000		1,390,000
Selling, general and administrative expenses (including research and development)	5,029,000		1,921,000
Other (gains) and losses			191,000
Operating income	-780,000		-722,000
Depreciation and amortization	1,499,000		701,000
Identifiable assets	171,559,000		71,814,000
Capital expenditures	951,000		8,209,000
Unallocated [Member]
Segment Reporting Information [Line Items]
Revenue		[1]		[2]
Selling, general and administrative expenses (including research and development)	4,604,000		4,103,000
Operating income	-4,604,000		-4,103,000
Depreciation and amortization	106,000		148,000
Identifiable assets	899,000		42,256,000
Capital expenditures	$496,000		$9,000
[1]	Excludes revenue from internal customers of $0.4 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment atcost.
[2]	Excludes revenue from internal customers of $0.7 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment atcost.

Note_15_Industry_Segments_Deta2

Note 15 - Industry Segments (Details) - Reconciliation of Total Segment Operating Income to Total Earnings from Operations Before Income Taxes (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Reconciliation of Total Segment Operating Income to Total Earnings from Operations Before Income Taxes [Abstract]
Operating income for reportable segments	$3,660	$12,346
Interest income	4	8
Interest expense	-362	-247
Loss on foreign currency	-545
Other expense, net	-110	-56
Income before income taxes	$2,647	$12,051